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ABSTRACT
THE ROLE OF LIPOTEICHOIC ACID AND THE LEUKOCYTE INTEGRINS IN
THE BINDING OF GROUP B STREPTOCOCCI TO MURINE PERITONEAL
MACROPHAGES

Anne R. Sloan
University of New Hampshire, May, 1992

The macrophage has been shown to bind potentially pathogenic
bacteria in the absence of serum components, but the mechanism is not well
understood.

The macrophage is a key component of our non-inducible

defenses and this form of innate immunity is of particular importance for
individuals in which the immune system may be sub-optimally functional,
e.g., neonatal and geriatric individuals, and for sites in the body in which
serum enhancement through opsonins is thought to be insufficient, e.g.,
lungs. To understand the mechanism by which mammalian innate host
defenses respond to potential microbial aggression by opportunistic
microorganisms, I developed two assays to quantify the in vitro, serum-free
adherence of group B Streptococcus to murine peritoneal macrophages. The
first is a modified direct microscopic assay, while die second is based upon an

enzyme-linked assay using bacterial specific antibody.
Sugar inhibition assays as well as studies with isogenic strains and
neuraminidase-treated streptococci could not confirm a mechanism proposed
by other investigators that macrophages recognize these streptococci by a
lectin-like receptor for galactose. I observed that binding characteristics of the
macrophage, such as temperature- and divalent cation- dependence, protease
sensitivity, and enhancement by fibronectin and phorbol esters, were similar
to those of the

integrins, a heterodimeric family of leukocyte receptors.

Monoclonal antibodies M l/70, which recognizes the a-subunit of one
member of the family, complement receptor 3 (CR3), and M18/2, which
recognizes the P-subunit, common to all three members, were each shown to
reduce bacterial adherence in down-modulation, flow cytometric and soluble
inhibition studies. Using similar approaches I have additionally shown that
the purified streptococcal membrane phosphosugar, lipoteichoic acid, can
inhibit the binding of these bacteria to macrophages. These results support
roles for both lipoteichoic ad d and the P2 integrins in the innate recognition
of group B streptococd by macrophages.

INTRODUCTION

Phagocytic cells in higher animals are capable of discriminating between
foreign material and self components, as well as between self and altered self
(47). This recognition ability is thought to have developed with the
evolution of multicellular life forms, since primitive colonial marine species
such as Porifera exhibit the ability to exclude non-self life forms (105).
Concomitantly the generalized process of phagocytosis became associated with
specialized cells in metazoans (26). Hemocytes from invertebrates have been
shown to perform many of the functions associated with phagocytic cells in
well-studied mammalian systems (67).
In vertebrates a highly adaptive immune system has evolved, involving
extensive cooperation between cellular and humoral components and the
concept of specialized recognition (84), and this facet of the host's defenses has
been the subject of comprehensive studies. The more primitive forms of
phagocyte recognition appear, however, to have been retained and the cells
appear capable of recognizing foreign particulate material without the use of
their more recently evolved receptors for the Fc component of the
immunoglobulin molecule or the C3b component of the complement system
(94).
The mechanisms that underlie these highly important recognition
1
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abilities of phagocytes is not fully understood. It is not known if the binding
of a bacterium to a phagocytic cell involves complex stereospedfic receptors in
the cell for components of the cell surface of the microorganism or whether
the binding depends on a simpler, relatively nonspecific ability to recognize
carbohydrate or other cell surface constituents. Such interactions may depend
on hydrophobic molecules present in the foreign particle inserting
themselves in the phospholipid cell membrane of the phagocytes (109).
Cell membranes contain lipids, proteins, oligosaccharides and
polysaccharides in various combinations (91). Membrane phospholipids
have hydrophilic polar heads that interact with water at the external and
internal sides of the phospholipid bilayer. Their hydrophobic tails associate
within the bilayer and are excluded from water. These molecules are capable
of lateral movement in the membranes. Membrane proteins exist in
hydrophilic and hydrophobic forms. The hydrophobic proteins (integral
membrane proteins) are embedded to variable depths into the phospholipid
bilayer and may span the membrane. In the latter situation they will have
hydrophilic peptide sequences at either end of the molecule. Such molecules
often have a carbohydrate chain at the external surface of the bilayer and are
glycoproteins. Other non-structural proteins with hydrophilic properties are
present at the external and internal surfaces of the lipid bilayer and are called
peripheral membrane proteins.
Peripheral membrane proteins can be dissociated from integral membrane
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proteins and giycolipids by high salt concentration and chelating agents (33).
Their removal, in contrast to the integral proteins, usually does not affect the
structural integrity of the cell membrane. Some integral proteins can, like the
phospholipids themselves, move laterally in the membrane. Membrane
glycoproteins and giycolipids are arranged so that their carbohydrate residues
are exposed at the external surface of the membrane. Many of these
molecules are known to act as receptors for antibodies, hormones, viruses,
and other agents. Their lateral movement can result in the formation of
patches or caps in which their distribution is altered from a diffuse to a
coalesced arrangement.
Microtubules together with microfilaments lie in the cytoplasm of the cell
and control the mobility and distribution of cell surface receptors (62). The
fact that different integral proteins and glycoproteins have considerably
different rates of lateral movement suggests the importance of restricted
mobility of some components so as to maintain an ordered display of patterns
on the cell surface. Such cell-specific surface patterns could constitute an
important mechanism for determining cell contact and recognition
phenomena. The ability of some of these molecules to move rapidly in the
cell membrane in response to environmental factors, such as complement or
antibodies, enables reversible changes in the cell surface pattern to take place.
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Non-opsonin-mediated recognition o f bacteria by macrophages
Serum factors have been shown to enhance the rate of uptake of
microorganisms by phagocytes since the early 1900's (111). Over the years it
has been established that the primary role of the opsonins is to provide a
means of recognition between phagocytes and their targets, e.g., bacteria (33,
50) in a process known as opsonophagocytosis.
Opsonophagocytosis can occur in three modes (82). In the first, only
antibodies participate by reacting via their (Fab)2 combining sites with the
appropriate antigenic determinants on the bacterial surface. The Fc portion of
the coating immunoglobulin G molecule binds to the corresponding Fc
receptors on the surface of the phagocytes, thereby bringing the microbe and
phagocytic cell in close proximity. In the second mode, only the C3b and C3bi
fragments of complement participate. The C3b and C3bi fragments are
generated from C3 as a result of its activation by contact with certain microbial
surface constituents, a process known as the alternative pathway of
activation. C3b or C3bi attaches to the microbial surface covalently via thiol
ester or amide bonds and to the phagocyte surface via specific receptors
known as CR1 or CR3, respectively (50).
In the third mode, both antibody and C3b (or C3bi) participate. The
antibody binds to the microbial surface antigens, and the antigen-antibody
complexes thus formed activate complement, either by the classical pathway
or the alternative pathway, following which C3b or C3bi is deposited onto the
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microbial surface. The microorganisms, which are now coated with both
antibody and complement fragments, bind to the phagocytes via the receptors
for both ligands. This binding is greatly enhanced over that with either
immunoglobulin G or the fragments of C3 alone (52).
The second mode of opsonophagocytosis has been a subject of much
interest, since it can occur in the non-immune host, and therefore serves as
an early defense mechanism against microbial infections (25). It depends on
the availability of complement at the site of infection, on the ability of bacteria
to activate complement by the alternative pathway and to deposit fragments
of C3 on their surfaces, and on the proper orientation of the cell-bound
fragments to react with the appropriate receptors on the phagocytes. These
conditions are not always met. Certain sites, such as the lungs (28,51) or renal
medullae (85, 86 ) have low serum opsonin concentrations, which may not be
sufficient to effectively opsonize many bacterial species. Additionally, not all
organisms activate the alternative pathway efficiently (25,42, 66 ), and
complement-deficient states have been reported during the neonatal period
(1,15). Moreover, patients deficient in C3 can frequently cope with a variety
of bacterial infections, irrespective of the ability of the bacteria to activate the
alternative pathway.
Evidence from in vitro studies demonstrates that phagocytosis of bacteria
occurs in opsonin-free media (20,33,43, 53,69,70,101), while that from in
vivo studies shows clearance of bacteria from the lungs by alveolar
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macrophages (28, 51) or from the blood by the reticuloendothelial system of
animals depleted of complement (11). Nonopsonic recognition between
bacteria and phagocytes may be occurring by one or more mechansims.
Several investigators have postulated that the net surface charge or the
hydrophobicity of particles or bacteria determines whether they can be bound
by phagocytes (92,102), but no direct evidence for these assumptions has been
obtained. It is still possible that nonspecific or ill-defined surface properties
may account for the recognition by phagocytes of some particles (e.g.,
polystyrene beads). However, as pointed out by Griffin (33), recognition of
most physiologically relevant particles must involve more specific
mechanisms.

The role o f lectins in recognition o f microorganisms by phagocytic cells
During the last decade considerable evidence has accumulated showing
that specific recognition by phagocytes may be accomplished by the interaction
of carbohydrate-binding proteins, e.g., lectins, on the surface of one type of cell
that combine with complementary sugars on the surface of another in a lockand-key manner (82,83). This type of recognition, which also leads to
phagocytosis, has been termed lectinophagocytosis (60). Lectinophagocytosis
of bacteria can occur in two major modes. In the first, bacteria that carry
surface lectins bind to complementary carbohydrates on the surface of the
phagocytic cells. In the second, lectins that are integral components of the
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phagocytic cell membrane bind to carbohydrates on the bacterial surface.
Macrophages have several cell-associated lectins that have been implicated
in microbial recognition (30). A receptor on human macrophages has been
shown to recognize mannose-bearing pathogens and to mediate their
internalization (24). This mannose/fucosyl receptor (MFR) recognizes
Leishmania promastigotes and synthesis of reactive oxygen metabolites is
triggered by adherence to this receptor (46). Human monocytes bear |}-glucan
receptors that react with zymosan particles (19), thus providing the cells with
the ability to detect microorganisms bearing this glycan in the absence of
serum factors. The clearance of Klebsiella pneumoniae from the lung may be
due to a mannosyl/N-acetyl-D-glucosaminyl receptor found on alveolar
macrophages (7).
Rat Kupffer cells in vitro strongly bind neuraminidase-treated but not
untreated rat erythrocytes (49). Preincubation of the macrophages with Dgalactose and related sugars inhibits cell adherence and suggests that the
galactose-specific lectin receptor recognizes senescent erythrocytes (79).

The Group B Streptococcus
Group B streptococci (GBS) are a major cause of neonatal meningitis and
septicemia in this country (80). These organisms are classified into serotypes
based on their specific capsular polysaccharides. The capsular polysaccharides
of serotypes la, lb, II and m have been purified and characterized (39,38,41,
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40). The structure of the capsular polysaccharides for these serotypes is
represented in Fig. 1 (44). The backbone antigen is composed of a repeating
unit of two to five monosaccharides, depending on the serotype. Side-chain
pD-galactose may be either exposed or be covered by a terminal sialic add.
Type II strains, which account for ~15% of all infant infections, have been
isolated only rarely from infants with meningitis (108,110). Among GBS
isolates from adults with meningitis, however, type II strains predominate
(110). Of the defined capsular polysaccharides the type m capsule is found on
organisms most frequently isolated from neonatal infections. Although
frequently found among the flora colonizing the vaginal tract, they seldom
contribute to disease in the otherwise healthy adult host. During parturition,
particularly when accompanied by premature rupture of the fetal membranes,
GBS may be acquired by the newborn; systemic infection may follow (35).

Role o f complement receptor 3 (CR3) in host defenses
Adhesion between phagocytes and other cells is a necessary prerequisite
for phagocytosis (103). Phagocytosis represents an important effector
mechanism for the eradication of infectious agents and is performed
primarily by spedalized cells of two different lineages, namely
polymorphonudear neutrophilic granulocytes (PMN) and mononuclear
phagocytes (Mo). To fulfill their role in host defense, PMN and Me must
respond to specific signals that indicate the presence of infectious agents and
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Structural modifications of group B streptococcal polysaccharides
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3
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Fig. 1. Structure of GBS serotypes with modification by neuraminidase
treatment (2), from reference 44.
* site of cleavage by neuraminidase
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also collaborate with the elements of specific immunity. It has long been
assumed that these cells have specific receptors for binding microorganisms
directly, but only recently have such receptors been isolated and characterized.
The idea that a few receptors could be responsible for a wide range of
adhesion events first arose with the discovery of a class of patients that exhibit
recurrent life-threatening infections with gram-positive, gram-negative and
fungal pathogens (5). These patients exhibit extreme leucocytosis but fail to
form pus at sites of infection. In vitro experiments showed that PMN from
these patients are defective in adhesion to C3bi-coated erythrocytes, to proteincoated glass or plastic surfaces (3), and to endothelial cells (34), and that failure
to adhere results in the failure to display chemotactic responses. Thus,
susceptibility to infection probably results both from an inability to bind and
ingest opsonized pathogens and a failure to recruit cells to sites of infection.
More importantly, these observations suggest that the leucocytes of patients
fail to extravasate and are retained in the vasculature by a failure to adhere to
endothelial cells, giving the name of leucocyte adhesion deficiency (LAD) to
this condition. Characterization of the proteins missing from the patients'
leucocytes have confirmed their role in adhesion to endothelium and in
other adhesion events.
LAD is caused by a failure of leucocytes to express three related proteins,
LFA-1, CR3 and p i 50,95 of the integrin family of cell-cell and cell-matrix
proteins (90). Each of these cell-surface glycoproteins consists of an 04 ft
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dimer composed of a 150,-190,000 Mr a chain and a 95,000 Mr f) chain. The (3
chain is identical in each of these three proteins (77) and has been given the
designation CD18 by the International Workshop on Leucocyte Antigen
Differentiation. The a chains are structurally and antigenically distinct (113).
The a chains of LFA-1, CR3 and pl50,95 are termed C D lla, C D llb and CDllc,
respectively, and CR3 is referred to as CDllb/CD18.
LAD patients are deficient in all three of these proteins because of an
inherited defect in the (3 chain (90). Cells from LAD patients do synthesize
normal precursors of the a chains, but these precursors are very rapidly
degraded and do not appear on the cell surface. Patients have recurring
infections, often fatal in childhood unless they are corrected by bone marrow
transplantation. In a study by Ross et al. (73), children with LAD had
recurrent skin infections with Staphylococcus epidermidis but not yeast
suggesting the role of CR3 and LFA-1 in the phagocytosis of unopsonized
bacteria.
Lymphocytes express abundant LFA-1, but neither CR3 or pl50,95. PMN
express abundant CR3, whereas LFA-1 and p i50,95 are minor but easily
detectable components. Macrophages express large amounts of all three of
these proteins. Expression of these proteins appears to be restricted to
leucocytes; they have not been found on other mammalian cell types.
The first molecule shown to be deficient from LAD patients (6 ) had been
previously identified as a receptor for a cell-bound fragment of complement
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(114) and was named CR3 (complement receptor type three). CR3 has also
been referred to as Mac-1 and Mol because it was the first phagocyte-specific
antigen identified by monoclonal antibodies in mouse and man, respectively.
CR3 functions as an opsonic receptor, and promotes the binding of C3bicoated cells and particles by monocytes, macrophages and PMN (112,117). In
appropriately stimulated cells, binding is followed by phagocytosis of the
particle but does not induce reactive oxygen metabolites (21). Therefore, CR3
provides a safe way for entry into professional phagocytes, compared to
internalization via the Fc receptor. Most intracellular pathogens except
viruses, have been shown to use CR3 for entry into mononuclear phagocytes.
Examples are Legionella pneumophila (63), Mycobacterium tuberculosis (64),
Leishmania sp. (98), and Histoplasma capsulatum (12).
CR3 requires relatively high concentrations of divalent cations (about 0.5
mM Ca2+ and

M g2+)

in order to interact effectively with ligand (112). Integrin

a-subunits have three or four tandem repeats of a putative divalent cationbinding motif, and have been shown to require Ca?+ or Mg2+ for function (91).
This behavior contrasts with that of other opsonic receptors (CR1 and FcR)
which do not require divalent cations for binding activity. In addition, the
binding capacity of CR3 is temperature-dependent, and is absent in cells held
at 0°C (116), again distinguishing CR3 from other opsonic receptors (CR1 and
FcR) which bind well at 0°C.
In the presence of serum, most pathogens are taken up via C3bi
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deposition on their surface. CR3 does not recognize either the precursor C3b,
or the product of further cleavage C3dg (14,112,72). Binding of monomeric
or dimeric C3bi to CR3 has not been reported, presumably because of low
binding affinity. Studies using sheep erythrocytes coated with 104 to 105 O b i
per cell demonstrate avid binding to CR3-bearing cells presumably because of
multivalent interaction with the phagocytes. By analogy, it is likely that LFA1 and pl50,95 also bind their targets with low affinity and that adhesion
events mediated by these receptors are driven by multivalent interactions. A
functional consequence of low affinity binding is the potential to reverse
adhesion and promote detachment.
CR3 has two distinct binding sites. One is located on the a chain and binds
ligands such as O b i, containing the Arg-Gly-Asp (RGD) sequence. In the
absence of O b i, microorganisms expressing a surface protein containing the
RGD sequence could bind to CR3. For example, Bordetella pertussis, a gramnegative coccobadllus and the causative agent of whooping cough, has been
shown to adhere to human macrophages in vitro. The interaction between
macrophage CR3 and B. pertussis filamentous hemagglutinin (FHA)
involves recognition of the RGD sequence at positions 1097-1099 in FHA (68 ).
The other binding site on the a chain of CR3 has a lectin-like character
and, for example, recognizes lipopolysaccharide (LPS) located on the outer
leaflet of the outer membrane of Escherichia coli (103,116). Histoplasma
capsulatum binds directly to CR3 via the lectin-like binding site (94). In
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addition, an abundant surface glycolipid, promastigote lipophosphoglycan
(LPG), from Leishmania has been shown to bind to the 'lectin-like-LPS'
binding site on the a chain of CR3 (98,77). It is possible that LPS, LPG and H.
capsulatum display a common structure, such as a sugar phosphate, that can
be recognized by CR3 (116).

Lipoteichoic acid as bacterial ligand for CR3
Group B streptococci contain membrane teichoic add, lipoteichoic add
(LTA), which is known to mediate the adherence of GBS to human
embryonic, fetal and adult epithelial cells (55). The membrane teichoic adds
found in gram-positive bacteria exhibit a rather uniform structure:
polyglycerol phosphate polymers with D-alanine and saccharides as
constituents. (107). The hydrophobic end of the molecule interads with the
lipid bilayer of the membrane in combination with glycolipids or
phospholipids. The hydrophilic chain of the teichoic add, located on the
outer surface of the membrane, extends into the space between the membrane
and cell wall. Electron microscopy of bacteria using ferritin-labeled antibodies
to LTA have shown that the polymer extends from the outer surface of the
membrane through the cell wall and beyond the outer boundary of the cell
into the external environment. The length of the membrane teichoic add
chain corresponds to the thickness of the cell wall as observed by electron
microscopy.
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Lipoteichoic add from group B streptococd consists of a glycerol phosphate
chain attached to a terminal lipid residue, identical in character to a free
glycolipid of the cytoplasmic membrane. The glycerol phosphate backbone is
substituted with glucose (55). Results from the study of Nealon and Mattingly
(55) indicate that the binding mechanism of LTA from GBS to human
embryonic and fetal cells is temperature dependent and is influenced by both
the lipid moiety and the glycerol phosphate backbone. The binding of LTA
appears to involve a hydrophobic interaction which is dependent on the
membrane fluidity of the human cells as well as a hydrophilic interaction of
the glycerol phosphate backbone with spedfic receptor sites on the human
cells. The structural similiarities of the sugar phosphate part of the LTA
molecule with that of both LPG and LPS, which are known to be bacterial
ligands for CR3, suggest a possible role for LTA in the adherence of GBS to
macrophages.

CHAPTER 1

A QUANTITATIVE METHOD FOR MEASURING THE ADHERENCE OF
GROUP B STREPTOCOCCI TO MURINE PERITONEAL EXUDATE
MACROPHAGES
Abstract
I have developed a solid phase, direct binding, enzyme-linked immuno
sorbent assay (ELISA) to detect and quantify the adherence of group B
streptococci to murine macrophages. The assay correlated well with direct
microscopic quantification of adherence. As few as 3.8 x 104 bacteria per assay
well or less than 1 bacterium per macrophage could be detected. This assay is
both quantitative and selective, and is readily adaptable for m ultiple sample
analysis. It provides a valuable alternative to visual detection of bacterial
adherence.

Introduction

The group B streptococcus (GBS) is the single m ost common agent
associated with bacteremia and meningitis during the neonatal period (75).
Polymorphonuclear neutrophils are known to phagocytose and destroy these
bacteria, but this requires opsonization w ith either specific antibody or
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complement (88 ). I have been examining the possibility that in individuals
such as neonates, for whom serum opsonins may not yet be fully functional,
macrophages serve to recognize and destroy potential pathogens in the
absence of serum factors. As part of that study I required an in vitro binding
assay for measuring the adherence of GBS to host defense cells.
My initial studies used the binding assay developed by Glass et al. (27),
which involves the direct microscopic examination of stained cells.
Although a valuable assay, it suffers from several limitations. The procedure
is labor-intensive, the data are subjectively derived, and the assay lacks good
reproducibility. Other protocols for m easuring bacterial attachm ent to
eukaryotic cells have been developed, including ones using fluorescenceactivated cell sorting (61), fluorescence microscopy (59), radiolabeled bacteria
(104), or electronic particle counters (31), but none provides the composite
attributes of repeatability, versatility, and low cost I sought.
Ofek et al. (59) reported on a ELISA-based system for determining the
adherence of bacteria to enterocytes or oral epithelial cells. Subsequently
Athamna and Ofek (7) applied this approach to quantify the adherence of
Klebsiella pneumoniae to mouse peritoneal macrophages. Here I report on
an adaptation of this technique for quantifying adherence of a gram-positive
bacterium to phagocytic cells.

18
M aterials and m ethods

Bacteria Type II group B streptococci, strain 18RS21 (44), kindly provided by
Dr. Dennis Kasper, Harvard Medical School, Boston, MA, were grown in
Todd-Hewitt broth (Difco Laboratories, Detroit, MI) at 37°C to mid-log phase
under static conditions. The bacteria were harvested by centrifugation and
were washed in Dulbecco's phosphate-buffered saline (DPBS). Stock
suspensions of GBS were stored at -70°C in DPBS containing 8 % dimethylsulfoxide (DMSO; Sigma Chemical Co., St. Louis, MO). Before use in each
assay frozen aliquots were thawed, washed with DPBS, and adjusted to the
appropriate density. The concentration of bacteria in the suspension was
determ ined by direct counts in a Petroff-Hausser chamber (C. A. Hausser and
Son, Philadelphia, PA).

Macrophages Peritoneal exudate macrophages (pMe) from 8-12-week-old
female BALB/c mice (originally obtained from Charles River Laboratories,
W ilmington, MA and subsequently bred at our institution) were elicited by
intraperitoneal injections of 2 ml of Brewer thioglycollate (Difco Labora
tories). After 3 days the pMe were harvested by lavage using 10 ml of cold
Medium 199 with Earle's salts (M199; Gibco Laboratories, Grand Island, NY).
The pMe were washed twice by centrifugation at 100 x g, using cold M199 and
resuspended in M199 to a concentration of 106 cells/m l.
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Antibody Rabbit antiserum against the cell wall polysaccharide of type n GBS
was kindly provided by Dr. Dennis Kasper.

Cell lines The WISH (ATCC CCL 25, Rockville, MD) and L929 (ATCC CCL1)
cell lines were used as controls for bacterial attachment. Both cell lines were
m aintained in log phase using Minimal Essential Medium (MEM) with
Earle's salts containing 15% fetal bovine serum (Hydone Laboratories, Logan
UT), 2 mM L-glutamine (Gibco), and 100 pM non-essential amino adds
(Gibco) at 37°C with 5% CO2, 95% air. The cell lines were harvested using
0.05% trypsin-EDTA (Gibco) and resuspended in M199 at a concentration of
10^ cells/m l.

Immobilization o f cells onto the microtitration plate Two-hundred micro
liters of pMa or of control cell lines (106 cells/m l) were distributed to the wells
of a 16-chamber glass slide (Lab-Tek, Nunc, Inc., Naperville, IL). The cells
were sedimented to the bottom of the plate by centrifugation at 100 x g for 5
min (Beckman model TJ-6 ; with micro-plate carrier for the TH-4 rotor), then
allowed to attach for 3 h at 37°C. The cell monolayers were washed twice
with DPBS to remove unattached cells.

Microscopic assay for measuring GBS binding to pMo I developed a modifi
cation of the original procedure (27). Suspensions of GBS in 100 pi of DPBS, at
concentrations of 109, 2 x 106, and 4 x 107 bacteria/m l, were added to the pMe
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and control cells in duplicate. After incubation at 37°C for 1 h the wells were
washed 4 times with DPBS to remove nonadherent bacteria. The chambers
were then removed and the slide air-dried, fixed in methanol, and stained
with a modified W right's stain (Leukostat, Fisher Scientific, Pittsburgh, PA).
Approximately 200 pMe were examined per well for bacterial adherence.
Those with 2 or more (27) or 5 or more bacteria attached were scored as
positive.

ELISA Suspensions of GBS in 100 pi of DPBS, at concentrations of 109,2 x 108,
and 4 x 107 bacteria/m l were added to the macrophage and control cells in
quadruplicate. After incubation at 37°C for 1 h the wells were washed four
times with DPBS to remove nonadherent bacteria. The plates were air-dried
and fixed with methanol for 10 min. Bacteria extracellularly attached to
macrophages or control cells were quantified by ELISA.
The choice of a control for bacterial adherence is crucial. We attempted to
use empty plastic wells or wells coated with protein blocking agents such as
bovine serum albumin, gelatin, or hemoglobin (59) as negative controls. In
all cases I found a high degree of bacterial adherence to the em pty wells or
protein-coated wells when compared with bacterial attachm ent to pMe. For
this reason I chose to compare bacterial attachment to two types of easily
obtainable, non-phagocytic cell lines with that of the macrophage. By using
either the epithelial-like WISH cell line or the fibroblast-like L929 cell line as
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controls for non-specific attachment of GBS to the wells of the assay chamber,
I obtained low background ELISA readings in these wells, compared with
ELISA values for GBS adhering to pMo.
The procedure of Athamna and Ofek (7) was modified for use with our
system. To each well, containing methanol-fixed cells, was added 200 pi of 20
mM phosphate, 0.15 M NaCl (PBS), pH 7.2, containing 1% gelatin (Bio-Rad
Laboratories, Richmond, CA), to block nonspecific binding of antibody, and 10
p g /m l of goat immunoglobulin G (Organon Teknika Corp., Durham, NC), to
block the Fc receptors on the macrophages. After incubation for 1 h at 37°C,
the monolayers were washed three times with PBS containing 0.05% Tween20 (Bio-Rad; PBS-Tween), followed by the addition of 100 pi/w ell of specific
anti-GBS serum diluted 1:500 in PBS containing 1% gelatin and 0.1% Tween20 for 1 h at 37°C. The plates were washed three times with PBS-Tween,

followed by the addition of 100 pi per well of horseradish peroxidase-labeled,
affinity-purified anti-rabbit immunoglobulin G (Organon Teknika), diluted
1:5000 in PBS-Tween + gelatin for 1 h at 37°C. After three washes with
PBS-Tween, 200 pi of the substrate 3 ,3 ', 5 ,5'-tetramethylbenzidine (TMB;
Sigma) in acetate buffer was added to each well. Since TMB is poorly soluble
in aqueous solution, it was first dissolved in DMSO to a final concentration of
42 mM and 1 ml of this TMB-DMSO solution was added dropwise with gentle
shaking to 100 ml of 0.1 M sodium acetate-citric ad d buffer, pH 4.9. Just before
use, 14.7 pi of 30% hydrogen peroxide was added to the acetate buffer contain-
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ing TMB for a final concentration of 1.3 mM H 2O2. H ie blue color was
allowed to develop for 15 min at room tem perature and the enzyme reaction
was stopped with the addition of 50 ill of 2.0 M H 2SO4 to each well. The
absorbance was read at 450 nm (A450) with an ELISA plate reader (Whittaker
M.A. Bioproducts, Inc., Walkerville, MD). The following control systems
were included: [1] blank wells (no bacteria or eukaryotic cells), [2 ] wells with
macrophages only (no bacteria), and [3] wells with control cells (no bacteria).
These controls were included to ensure that the eukaryotic cells did not crossreact with the first antibody and to detect any nonspecific binding of the
antibodies.

Determination o f the number o f bacteria per monolayer A standard curve
made for each test served to estimate the number of bacteria per monolayer.
For this purpose GBS of known concentration in 100 |il of distilled water was
placed in the wells of a microtitration plate and allowed to dry overnight in a
desiccator, followed by fixation with methanol for 10 min. An ELISA was
performed on the immobilized bacteria as described above. The ELISA
values, at A450, were plotted as a function of the num ber of bacteria in each
well. The curve obtained was used to calculate the num ber of bacteria
attached to the pMo or cell line monolayer from the ELISA values obtained
in the test experiment.
The standard curve was adjusted for loss of dried bacteria due to washing
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following the procedure of Athamna and Ofek (7). GBS were grown in tryptic
soy broth (Difco) containing 1.5 pCi of 5-[1251]iodo-2'-deoxyuridine (NENDupont, Boston, M A)/m l to mid-log phase at 37°C under static conditions.
The radiolabeled bacteria were harvested by centrifugation and washed free of
excess radioactivity with DPBS. The bacteria were adjusted as above to the
desired concentration and the radioactivity associated with the cells was
determined using a gamma counter (Gamma 5500, Beckman Instrum ents,
Inc., Fullerton, CA). The radiolabeled bacteria contained 3800 cpm /10 7
bacteria. The bacterial suspension was diluted in distilled water, dried, and
fixed onto two sets of flat-bottomed EIA/RIA Strip-Plate-8 (Costar Corp.,
Cambridge, MA). One of the sets was washed 9 times with PBS-Tween to
duplicate ELISA washes and the radioactivity of the individual wells of the
two sets was determined.

Determination o f the number of pM e per well This determ ination was
based on the selective staining of the pM e nuclei w ith methylene blue,
followed by extraction of the stain (10). Known concentrations of pMa in 100
pi of M199 were sedimented in the wells of a m icrotitration plate, air-dried,
and fixed with methanol. These monolayers were stained with 100 pi of 1%
methylene blue solution/w ell for 10 min, followed by washing with boric add
buffer (0.1 M boric add, 0.1 M KC1, pH 8 .6 ). The stain was extracted by adding
0.1 N HC1 and the recovered solution read at A^o nm in the ELISA plate
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reader. The A«o values of the extracted stain were plotted as a function of the
number of pMe in each well to obtain a standard curve. This curve was used
to estimate the number of pMo in each experimental well after extracting and
reading the methylene blue stain from each test monolayer.
A standard curve made for each test served to derive the number of pM e
per monolayer. After determination of the num ber of bacteria in the experi
mental assays was completed, the same monolayers were washed and stained
to quantify the number of pMe, using the standard curve previously derived.

Results

Standard curves for adherence o f GBS and pMo In order to quantify bacterial
adherence using the ELISA system, it was first necessary to construct standard
curves to determine the number of bacteria and of macrophages in each
system. Serially diluted suspensions of GBS, dried and fixed on microtitra
tion plates, were reacted with the ELISA reagents. As shown in Fig. 1, a linear
relationship between the number of immobilized bacteria (expressed logarith
mically) and the ELISA values was obtained over the range of 6 x 104 to 6 x 10*
bacteria/w ell. To determine whether significant numbers of bacteria were
lost during washing, surface-labeled (1251) bacteria were dried and fixed to the
bottom of microtitration plate wells. One series was washed nine times while
the others remained unwashed. The amount of remaining radioactivity was

!
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Fig. 1. Standard curve for the determination of numbers of bacteria per well.
ELISA values (A450) as a function of increasing numbers of dried,
immobilized streptococci
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determined for each sample. The data, depicted in Table I, indicate there was
negligible loss of radioactivity, and hence of bacteria, due to washing over the
concentration range of 2 x 103 to 2 x 108 bacteria added.
The number of adherent pMo was estimated by staining w ith methylene
blue and quantifying the extracted dye. As shown in Fig. 2, the A*20 values of
the extracted methylene blue were linear over the range of 105 to 106
pM o/well. These standard curves were made in each experiment and used to
determine the number of adherent bacteria per pMo, which was calculated by
dividing the total number of adherent bacteria by the total num ber of
pM o/well.

Adherence assays measured by ELISA The number of pMo or control cells
added to each well of the assay plate was 2 x 10s. Approximately 1 x 105 pMo
were immobilized per well, as determined from the pM e standard curve.
This number of cells formed a complete monolayer covering the surface area
of the well. By visual inspection the WISH and L929 cells also completely
covered the surface area of the well. Thus, any differences in ELISA values
between wells containing immobilized pMe and those w ith control cells is a
reflection of specific bacterial adherence to the pMe.
The adherence of GBS to pMo was dose-dependent over the concentration
range of bacteria added, namely 4 x 106 to 1 x 108/ well. Adherence of less than
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TABLE 1
EFFECT OF WASHING ON THE ADHERENCE OF BACTERIA
Use of 1251-labeled GBS

No. of bacteria

CPM for

Percentage

rem aining
after washing

added

non-washed*

2x108

36403±353

356871477

98

4x107

69901116

6848165

98

8x106

1372115

135318

99

washed 2

1.6x106

301 ±13

323112

107

3.2x105

106111

104119

98

6.4x104

5718

58113

102

1.3x104

4317

50116

116

2.6x103

4915

5413

110

2 Mean ± S.E. (n = 4)

0

1

2

3

Bacteria/well

Fig. 2. Standard curve for the determination of numbers of macrophages per
well. Values of extracted methylene blue stain (A*2o) as a function of number
of sedimented and dried peritoneal macrophages.

29
one bacterium per cell was detected by the ELISA technique (Table 2). To
confirm that ELISA readings corresponded to bacterial adherence to pMe, the
bottoms of the wells were cut off and m ounted onto a glass microscope slide,
and the num ber of adherent bacteria per pMo or control cell was counted
microscopically. There was a good correlation between the ELISA readings for
adherence and the values obtained by direct microscopic counts.
Comparable studies performed with non-phagocytic cell lines revealed
significantly lower values for microbial adherence. Even at the highest
dosage tested (1 x 108 bacteria added), the binding ratios were at least ten-fold
lower than those for pMo.

Visual assay for detecting microbial attachment Standard adherence assays
were performed by a modification of the technique developed by Glass et al.
(27). For each assay system two values were determined: the number of pMe
with 2 2 bacteria attached and the number of pMe with £ 5 bacteria attached.
The former is the value used in the original description of this protocol,
while the latter is a more rigorous criterion used in our laboratory.
The results of these assays are summarized in Table 3. As expected, there
was a positive correlation between the num ber of bacteria added and the
percentage of pMo exhibiting adherence. This was true regardless of which
binding criterion was used. At the higher level of GBS added (1 x 108)
virtually all the pM e bound at least 2 bacteria; however, only one-third of
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TABLE 2
ATTACHMENT OF GROUP B STREPTOCOCCI TO MACROPHAGES AND
CONTROL CELL LINES
Number of bacteria per well is based on ELISA values.

Cells

pMo

L929

WISH

GBS added/w ell

Mean no. (± S. E.) of

GBS/Mo*

GBS bound per Meb

1x108

1000:1

8.5 ±1.7

2x107

200:1

1.5 ±0.4

4x108

40:1

0.38± 0.03

1x108

1000:1

0.67± 0.10

2x107

200:1

0.27± 0.06

4x106

40:1

0.13± 0.04

1x108

1000:1

0.53± 0.06

2x107

200:1

0.22± 0.04

4x106

40:1

0.15 ±0.01

a-1 0 5 M o/w ell
b n = 12

Ratio of added
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TABLE 3
ATTACHMENT OF GROUP B STREPTOCOCCI TO MACROPHAGES AND
CONTROL CELL LINES
Numbers are based on visual assessment by direct microscopic counting

Cells

GBS added

Percentage with
2 2 bacteria/cella

pMo

L929

WISH

£ 5 bacteria/cella

1x108

96 ±1.2

33 ±3.5

2x107

82 ±1.7

9.7± 2.1

4x106

10 ± 2.0

1.9± 0.8

1x108

7.6± 1.1

2.7± 0.42

2x107

1.9± 0.02

0.13 ±0.02

4x106

0.40 ±0.04

0.05± 0.02

1x108

6.0 ±0.57

2.3± 0.4

2x107

1.6 ±0.26

0.09 ±0.02

4x106

0.34 ±0.05

0.05 ±0.03

a Mean ± S. E. (n = 6 )
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them scored positive when the criterion was 2 5 bacteria bound per cell.
Comparable studies with non-phagocytic cell lines revealed adherence values
10 times lower for each concentration of GBS tested, confirming that the
adherence was not a general eukaryotic cell function.
As shown in Fig. 3, there was good correlation between the ELISA readings
for adherence and the values obtained by direct microscopic counts.

Discussion

Phagocytosis of microorganisms is an im portant host defense among
members of the animal kingdom. In order for phagocytosis to be initiated
there m ust be contact between the engulfing cell and the potential pathogen.
Assuming that these are not chance encounters there m ust be some form of
recognition between these two participants. In the case of non-opsoninmediated phagocytosis the ability to phagocytose microorganisms must be due
to inherent properties of the host cell, most likely structures located on the
plasma membrane.
As part of our studies to identify the receptor on the mouse pMo respon
sible for recognition of GBS I sought a relatively inexpensive binding assay
that could be readily performed and would give reproducible results. An
enzyme-linked assay has the potential to provide objective data and to allow
simultaneous testing of m ultiple variables. Athamna and Ofek (7)
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100

ELISA

Fig. 3. Comparison of bacterial binding obtained from the direct visual assay
and from ELISA. Plot with open squares relates results from visual assay (Me
binding 2:2 bacteria) with ELISA data (number of bacteria bound per Me).
Plot with closed squares depicts a comparable relationship between visual
assay (Me binding 2 5 bacteria) and ELISA data.
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developed an ELISA-based adherence assay using K. pneumoniae and mouse
pMe. My studies indicate that this assay can be modified to detect binding of
GBS to pMe.
In this system bacteria are allowed to adhere to monolayers of pM a and
their presence is both detected and quantified by an ELISA, using specific
antibody to the bacteria as the primary antibody. To calculate binding ratios it
was first necessary to verify the numbers of each cell type in our assay
chambers. Standard curves plotting the numbers of bacteria per well vs.
absorbance at 450 run (to detect the product formed by horseradish peroxidase
in the antibody-enzyme conjugate; Fig. 1) and the number of pM e per well vs.
absorbance at 620 nm (to detect the methylene blue eluted from stained pMo;
Fig. 2) each yielded sigmoidal dose-response curves with linear mid-sections.
Using this approach determined the binding ratios for GBS and m urine
pMo. As shown in Table 2, the data obtained are highly replicable. At high
ratios of added bacteria to pMe (1000:1) our system detected 7-10 bacteria per
pMe, whereas at a lower ratio (200:1) there were 1-2 bacteria detected per pMe.
Under comparable conditions the control eukaryotic cells consistently
exhibited bacterial binding ratios of <1 per cell.
Data presented in Table 3 provide information obtained from bacterial
binding studies using direct microscopic counting. As with the ELISA-based
system, results from the direct counting assays also yielded a positive doseresponse effect. Similarly, the control cells gave consistently low binding
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values.
Although the ELISA-based system for quantifying bacterial binding to
eukaryotic cells provides some obvious advantages over direct visual assay,
each system is, in fact, assessing a somewhat different aspect of adherence.
Using ELISA we can obtain information on a population of Mo, but we
cannot determ ine the distribution of the bound and detected bacteria over
this population. That is, we can calculate an average binding ratio, e.g., 8.5
bacteria per pMe, but we cannot ascertain the binding properties of individual
Me; for this the visual assay system remains the definitive procedure.
Nonetheless the use of an ELISA-based approach to measure bacterial
adherence provides a valuable tool for screening various assay conditions or
treatments to determine their effect on b inding, since many variables can be
simultaneously tested. The ability of this system to detect as few as 3.8 x 104
GBS compares favorably with the data of Athamna and Ofek (7) in which they
detected 5 x 104 K. pneumoniae. These studies indicate that an ELISA-based
system has broad application in studies on microbial phagocytosis.

CHAPTER 2
CHARACTERIZATION OF THE MURINE MACROPHAGE RECEPTOR FOR
GROUP B STREPTOCOCCI

Abstract

I have examined the role of the galactose receptor for the non-opsonin
mediated adherence of group B streptococci (GBS) to m urine peritoneal
macrophages (Me). The effects of sugars and neoglycoconjugate proteins of
bovine serum albumin (BSA) that are known to bind to the lectin-like
receptor on the inhibition of GBS binding to peritoneal macrophages was
investigated. These studies required stringent conditions, both a visual assay
and enzyme-linked immunosorbent assay (ELISA), for quantifying binding
and the subsequent inhibition of binding. Using these assay conditions I
observed no inhibition of binding by monosaccharides, including methyl-Pgalactoside, at concentrations as high as 200 mM or the neoglycoconjugate
protein, galactose-BSA, at 2 m g/m l (-29 |iM galactose). To increase the
exposure of capsular galactose, terminal sialic add was removed by treating
GBS w ith neuram inidase from V. cholerae. Dose-dependent binding of
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neuraminidase-treated and untreated GBS types lb, II and HI was similiar. In
addition, the binding profile was similar for wild-type and isogenic strains of
type m GBS having no capsule or no capsular sialic add. Galactose or
galactose-BSA failed to inhibit binding of any of these strains. These results
suggest that there is no involvement of the galactose lectin-like receptor on
murine peritoneal macrophages with the binding of GBS in the absence of
serum opsonins.

Introduction

Group B streptococd (GBS) are a major cause of neonatal meningitis and
septicemia in the United States (80) and in post-parturn infections.
Increasingly they are being recognized as an important pathogen in non
pregnant adult humans as well (81). Phagocytosis of these organisms
followed by intracellular killing is considered to be the major host defense in
mammals and serum opsonins, e.g., anti-capsule antibody and complement,
have been shown to play a major role in effecting endocytosis (13).
GBS also bind directly to mammalian macrophages in the absence of
serum opsonins (see Chapter 1; ref. 25). Non-opsonin-mediated phagocytosis
can be achieved by membrane-assodated lectins on the macrophage reacting
with complementary sugar residues on the microbial surface (106, 82).
These baderia are typically encapsulated and the structures of these
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polysaccharide capsules form the basis of serotype designations (39,38,41.40).
Currently four serotypes, la, lb, n, and

m, are recognized; their basic structure

is shown in Fig. 1 (p. 9, Chap. 1; ref. 44). The backbone in each case is
composed of a repeating unit of 2 to 5 monosaccharides, while the side chain
P-D-galactose is either exposed or penultimate to a terminal sialic add.
My hypothesis, then, was that macrophage-derived lectins mediate the
recognition and binding of GBS. The data reported here do not support this
hypothesis.

M aterials and Methods

Chemicals All reagents were obtained from Sigma Chemical Co., St. Louis,
MO unless otherwise noted.

Bacteria Prototypic strains of GBS, representing two serotypes, originally
obtained from the late Dr. Rebecca Lancefield, Rockefeller University, were
provided by Dr. Dennis Kasper, Harvard Medical School. These strains are
designated H36B (type lb), 18RS21 (type II) (44). Two type m GBS strains M732
and COH31, originally clinical isolates from infants w ith meningitis (44), were
also provided by D. Kasper. All strains were obtained as frozen suspensions
of pure cultures, which were stored at -70°C. Each strain was streaked onto a
5% blood agar plate and incubated overnight at 37°C. A colony from each
strain was used to inoculate 10 ml of Todd-Hewitt broth (Difco Laboratories,
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Detroit MI) and this was incubated overnight to stationary phase. A 5-ml
volume of each strain was used to inoculate one liter of Todd-Hewitt broth
and this was incubated at 37°C to log phase under static conditions. The
bacteria were harvested by centrifugation at 10,000 xg for 10 min and were
washed three times in Dulbecco's phosphate-buffered saline (DPBS). Stock
suspensions of GBS were adjusted to a density of 1010/m l as determined by
direct counts in a Petroff-Hausser chamber (C. Hausser and Son, Philadelphia,
PA) and were stored at -70°C in DPBS containing 8 % dimethylsulfoxide
(DMSO). Before use in each assay, frozen aliquots from the original batch
culture of each strain were thawed and washed with DPBS to insure
continuity between experimental studies performed on different days.

Neuraminidase treatment o f GBS Desialylation of GBS strains H36B, 18RS21,
M732 and COH31 was done by adding 0.15 units of neuraminidase from
Vibrio cholerae, (Sigma, Type n, specific activity: 10 units/m g protein using
NAN-lactose) to 3 ml of bacterial suspension at 1010/m l in 0.05 M sodium
acetate buffer, pH 5.5, containing 154 mM NaCl and 9 mM CaCl2 (27). After 1
h at 37°C w ith constant end-over-end rotation, the bacteria were washed three
times with DPBS and stored in 8 % DMSO as described above. Nondesialylated bacteria were treated likewise but without the addition of neuramini
dase.

Isogenic strains o f type III GBS COH31 Capsular mutants of GBS type m
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strain COH31 obtained from D. Kasper (Harvard) were derived by Tn916
transposon mutagenesis. The m utant strain designated COH31-15 does not
react with type m GBS antiserum from rabbits and has no visible extracellular
capsule material when visualized by electron microscopy (45). Another
m utant strain designated COH31-21 is lacking terminal sialic ad d on the side
chain, leaving (to-galactose as the terminal sugar.

Interaction o f GBS with Ricinus communis agglutinin The availability of
galactose residues on the surface of GBS was verified by the aggregation of a
1% suspension of each strain by the galactose-specific lectin from Ricinus

communis (castor bean) at a concentration of 0.2 pg/m l. D(+)-Galactose,

d

(+ )-

glucose and methyl f)D-galactopyranoside were tested at concentrations of 10
m g/m l, 1.0 m g/m l and 0.1 m g/m l for their ability to inhibit the aggregated
GBS.

Detection o f fi-glucan receptor on Mo The P-glucan receptor found on Me
was used as a control system for the inhibition studies. Saccharomyces
cerevisiae and a preparation of its cell wall as particulate zymosan have been
shown to bind to Me in the absence of serum opsonins (96). Zymosan
partides consist almost exdusively of two types of carbohydrate polymers: pglucans, which are the major constituents, and a-m annans (22). Macrophage
binding of S. cerevisiae zymosan is inhibited most effectively by the soluble P*
glucans purified from yeast extract or yeast glucan partides with 1 3 - and/or

41
1,6-glycosidic linkages (37), whereas P-glucan from barley with 1,4-linkages are
not (17,18). Homopolysaccharides containing epim ers of glucose, such as
galactans and yeast a-m annans are not inhibitory even though they contain
1,3- an d /o r 1,6-linkages.
p-Glucan from 5. cerevisiae inhibits binding through the P-glucan
receptor (19). I have exploited this mechanism for macrophage binding to a
surface structure of yeast as a positive control in our inhibition studies. A
suspension of zymosan A from Saccharomyces cerevisiae, measuring 3-4 pm
in diameter, was prepared by sonication using a pulsed cycle for 30 seconds, at
output setting 4,50% duty cycle (Heat Systems Ultrasonics, Inc. Plainview,
NY) in DPBS. Soluble a-m annan and P-glucan from S. cerevisiae and pglucan from barley were tested for their ability to inhibit binding of zymosan
to Mo. The lowest concentration of each capable of yielding 50% inhibition of
zymosan attachment to Mo at particle concentrations of lOVml and 108/ml
was determined by the visual assay.

Macrophages Peritoneal exudate macrophages (Mo) from 8 to 12 week-old
female BALB/c mice were elicited by intraperitoneal injections of 2 ml of
Brewer thioglycollate (Difco Laboratories). After 3 days the Mo were har
vested by lavage using 10 ml of RPMI medium (Gibco Laboratories, Grand
Island, NY). The Mo were washed twice by centrifugation at 100 xg for 10
min, using cold RPMI and resuspended in RPMI to a concentration of 106
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cells per ml.

Antisera to GBS Group-specific and type-specific antisera to GBS, prepared in
rabbits, was kindly provided by Dennis Kasper, Harvard Medical School.

Binding Assays Adherence of GBS to Me was determined either by direct
microscopic observation or by an ELISA-based system, using previously
described methodology (see Chapter 1).

Inhibition studies Macrophage monolayers were pre-incubated with
monosaccharides in DPBS for 30 min and then for 1 h in the presence of
bacteria. The following monosaccharides were used at concentrations of 2,20
and 200mM: D(+)-galactose, methyl a-D-galactoside, methyl ^-D-galactoside,
D(+)-glucose, methyl a-D-glucoside, methyl ^-D-glucoside, D(+)-mannose,
methyl a-D-mannoside, methyl a-L-fucose, N-acetyl-D-glucosamine
(GluNAc) and iV-acetyl-D-galactosamine (GalNAc). Neoglycoconjugates
prepared by E Y Laboratories, San Mateo, CA, from bovine serum albumin
(BSA), containing 30 to 40 mole saccharide per mole BSA, were tested for
their ability to inhibit binding of GBS to macrophages. Glucosylated-,
galactosylated- and mannosylated-BSA were incubated w ith the Me
monolayers as described for the monosaccharide solutions at concentrations
of 20,200 and 2000 pg/m l. The concentrations of the monosaccharide were
equivalent to approximately 11,110 and 1100 pM, respectively.
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Unconjugated BSA, Fraction V, was included as a negative control at the
same protein concentrations.

Results

Effect o f sugars as inhibitors o f GBS adherence to macrophages A compar
ison was made between galactose and other monosaccharides as well as BSAglycoconjugates for the inhibition of type II and m GBS adherence to perito
neal macrophages. Using the visual assay I found there was no significant
inhibition of the binding of either serotype by galactose or any of the other
sugars at concentrations < 200mM (Table 1) or the neoglycoconjugates at
concentrations <2m g/ml (Table 2). The specific binding of zymosan particles
from S. cerevisiae to the p-glucan receptor on Mo was included as a positive
control to verify that the visual assay can quantify receptor inhibition (Table
3). The data in Table 1 suggest that the mechanism for type n and m
adherence was not due to the galactose receptor on the macrophage, since
there was no difference in binding by serotype or inhibition of binding
specifically by galactose.

Effect of desialylation o f capsular GBS polysaccharide The binding of GBS to
Mo may be due to more than one type of mechanism including the galactose
receptor. However, the inability of galactose to inhibit binding could be due
to the masking effect of terminal sialic acid. GBS types lb, II and m were
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TABLE 1
EFFECT OF MONOSACCHARIDES AS INHIBITORS OF GBS ADHERENCE
TOMo
Strain of GBS
In h ib ito r
PBS

18RS21
100± llb

M732

COH31

10018

100112

D(+)glucose

6 2 1 9c

55113

64112

Methyl-a-glucose

69113

45112

6016

Methyl-|)-glucose

5917

58110

7618

D(+)galactose

69112

5818

68115

Methyl-a-galactose

6418

55114

76112

Methyl-P-galactose

64110

55111

6816

L(-)fucose

6416

58111

7619

D(+)mannose

76114

6319

8010

M ethyl-a-mannose

71112

84114

90112

N-acetylglucosamine

6918

7717

96110

N-acetylgalactosamine

6618

6816

96110

a Inhibitors were used at concentrations of 200 mM
b Percentage binding ± S.E. (N=8)
c Analysis of variance for all systems (excluding PBS controls) indicated no
statistically significant difference in the effects of the test sugars on
bacterial adherence (F = 2.113; p = 0.0785)
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TABLE 2.
EFFECT OF BSA-GLYCOCONJUGATES AS INHIBITORS OF GBS
ADHERENCE TO Me
Strains of GBS
18RS21

M732

COH31

PBS

100 ±8b

100110

100115

Glucose-BSA

112±18c

10018

9619

Galactose-BSA

115 ±20

100110

11516

Mannose-BSA

112 ±9

94112

104112

Glucose/galactose-BSA

112112

115113

133115

Glucose/ mannose-BS A

106111

106115

136121

Galactose-mannose-BSA

11519

9417

133116

Inhibitors*

* Inhibitors were used at concentrations of 2 m g/ml.
b Percentage binding ± S.D. (N=8)
c Analysis of variance for all systems (excluding PBS controls) indicated no
statistically significant difference in the effects of the test glycoconjugates
on bacterial adherence (F = 1.18; p = 0.38)
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TABLE 3
INHIBITION OF BINDING OF SACCHAROMYCES CEREVISIAE ZYMOSAN
PARTICLES TO Me

Number of zymosan partides added
Inhibitor

10®/m l

108/ml

P-glucan (yeast)

0.5 mg/ml®

0.1 m g/m l

P-glucan (barley)

> 10 m g/m l

> 10 m g/m l

a-mannan (yeast)

> 10 m g/m l

> 10/m g/m l

a lowest concentration to yield 50% inhibition of binding. Representative
data from visual binding assay.
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treated with neuraminidase from V. cholerae to remove this sialic add. I
employed the lectin from Ricinus communis (castor bean) with a known
spedfidty for fi-D-galactose to determine if this residue was exposed following
neuraminidase treatment. Table 4 represents results by slide agglutination for
treated and untreated GBS. Agglutination of GBS by the castor bean lectin
was specifically inhibited by D(+)galactose and methyl-^-galactoside, whereas
D(+)glucose had no effed. Although desialylation by neuraminidase was
shown to expose galactose residues, dose-dependent binding of neuramini
dase-treated and untreated GBS type lb, II and m to Me as determined by
ELISA is similar (Figure 1).

Comparison o f type III isogenic strains for adherence to macrophages A
further study comparing macrophage adherence of wild-type COH31 to
isogenic strains of GBS type in, derived by Tn916 transposon mutagenesis and
having no capsular sialic add (COH31-21) or no capsule expressed (COH31-15)
was performed by the visual assay. Table 5 represents data from three
experiments in which the binding of all isogenic strains was similiar, about
35% and 12% for bacterial concentrations of 109/m l and 108/ml, respectively.
As in previous studies 200 mM galactose was shown to have no inhibitory
effect on the binding of any of the GBS isogenic strains to Mo, suggesting no
involvement of the galactose lectin receptor.
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TABLE 4
EFFECT OF MONOSACCHARIDES ON THE AGGLUTINATION OF
NEURAMINIDASE-TREATED AND UNTREATED GBS BY RICINUS
COMMUNIS AGGLUTININ

Inhibitor®
GBS strain

18RS21

Treatment^

PBS

D(+)-gal Me^-gal D(+)-glc

-

+

<10c

<10

>10

+

++

<1

<0.1

>10

-

-

NT

NT

NT

+

++

<1

<0.1

>10

-

-

NT

NT

NT

+

++

<1

<0.1

>10

COH31-15

-

-

NT

NT

NT

COH31-21

-

++

<1

<0.1

>10

M732

COH31

* inhibitors: PBS - control; D(+)-gal: D(+)-gaIactose; Mep-gal: methyl-{Jgalactoside; D(+)-glc D(+)-glucose
b +, neuraminidase-treated;

untreated

c concentration that effected 50% inhibition of agglutination; NT, not tested
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Fig. 1. Effect of neuraminidase treatment on adherence of four GBS strains to
Me. In each case (+) indicates treated system and (-), the untreated control.
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Fig. 1. (cont) Effect of neuraminidase treatment on adherence of four GBS
strains to Me.
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TABLE 5
EFFECT OF d(+)-GALACTOSE ON THE ADHERENCE OF GBS TYPE m
ISOGENIC STRAINS TO M0
Bacteria/ml
GBS strain

D(+)-gal added*

COH31

COH 31-15

COH 31-21

10®

30±2b

10 ± 2

33±4

12 ± 1

35 ± 5

9±3

30±4

12 ± 1

37 ± 3

13 ± 1

39 ± 6

14 ± 3

* - none added; +, 200 mM D(+)-galactose added
b percent binding ± S.D. (N = 6)

10»
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Discussion

Evidence from in vitro studies indicate that phagocytosis of bacteria occurs
in opsonin-free media (20, 33, 43, 53, 69, 70, 71), while findings from in vivo
studies show clearance of bacteria from the serum opsonin-deficient lungs by
alveolar macrophages (28, 51) or from the blood by the reticuloendothelial
system of animals depleted of complement (11). The molecular basis for nonopsonic recognition between bacteria and phagocytes is largely unknown.
Several investigators have postulated that the net surface charge or the
hydrophobidty of particles or bacteria determines whether they can be bound
by phagocytes (92,102), but no direct evidence for these assumptions has been
obtained. It is still possible that nonspecific or ill-defined surface properties
may account for the recognition by phagocytes of some particles (e.g., poly
styrene beads). However, as pointed out by Griffin (33), recognition of most
physiologically relevant particles must involve more specific mechanisms.
During the last decade, considerable evidence has accumulated showing
that specific recognition by phagocytes may be accomplished by the interaction
of carbohydrate-binding proteins, e.g., lectins, in the cytoplasmic membrane of
this defense cell with complementary sugars on the target cell (82,83). This
type of recognition, which also leads to phagocytosis, has been termed lectinophagocytosis (60). Macrophages have several cell-associated lectins that have
been implicated in microbial recognition (30). A mannose-spedfic receptor
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on human macrophages has been shown to recognize mannose-bearing
pathogens and to mediate their internalization (24). The mannose/ fucosyl
receptor (MFR) recognizes Leishmania promastigotes and synthesis of reac
tive oxygen metabolites is triggered by adherence to this receptor (46). Human
monocytes bear p-glucan receptors that react with zymosan particles (19), thus
providing the cells with the ability to detect microorganisms bearing this
glycan in the absence of serum factors.

The clearance of Klebsiella pneumo

niae from the lung may be due to a mannosyl/N-acetyl-D-glucosaminyl
receptor found on alveolar macrophages (7).
Rat Kupffer cells in vitro strongly bind neuraminidase-treated rat ery
throcytes but not untreated erythrocytes (49). Preincubation of the macro
phages with D-galactose and related sugars inhibits cell adherence and
suggests that the galactose-specific lectin receptor recognizes senescent
erythrocytes (79).
In this study we attempted to show involvement of the galactose receptor
for the non-opsonin-mediated adherence of GBS to peritoneal macrophages.
My results, however, do not support this hypothesis. First, none of the
monosaccharides or BSA-glycoconjugates acted as a specific inhibitor of type II
and m GBS adherence to macrophages (Table 1,2). Second, neuraminidasetreated GBS, which were shown to have galactose exposed on their surface by
agglutination with a galactose-specific lectin (Table 3), bound to peritoneal
macrophages, but the binding could not be reduced by pre-exposure of the
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macrophages to galactose (Table 4), again suggesting no involvement of the
galactose receptor on the macrophage. Third, isogenic strains of type HI GBS
having no capsule or no sialic add expressed, leaving galactose residues
exposed, exhibited the same degree of attachment as wild-type type III to
macrophages (Table 5).
Attachment with subsequent phagocytosis of microbial elements such as
zymosan mediated by the P-glucan-type lectin on the surface on the surface of
macrophages has been described by Czop et al. (19). This binding is inhibited
most effectively by the soluble P-glucan from S. cerevisiae with 1,3 or 1,6
glycosidic linkages (37); P-glucan from barley with 1,4 linkages is not inhibi
tory (17,18). Homopolymers containing epimers of glucose, such as galactans
or yeast a-mannans are also non-inhibitory, even though they contain 1,3 or
1,6 linkages. My results (Table 3) confirmed the presence of the P-glucan-type
receptor on the Me. Additionally, this system served as a positive control for
our inhibition studies.
Inhibition of blood clearance of neuraminidase-treated type I GBS, which
express galactosyl residues on their surfaces, was shown to be strongly inhibi
ted by galactosyl- but not by mannosyl- or fucosyl-BSA (65). In the same study
the blood clearance of type n GBS could be inhibited by neither galactosyl- or
mannosyl-BSA alone, whereas the presence of both neoglycoconjugates in the
injected suspension significantly inhibited the blood clearance of streptococci.
No such synergism was obtained in my experiments with type II and HI GBS

55
adherence to murine peritoneal macrophages. These results suggest that
lectins expressed on the surface of phagocytic cells in the liver are not present
on peritoneal macrophages. However, in the same study (65) the adherence
of type n GBS to Mo was inhibited by galactosy-, mannosyl- and glucosyl-BSA.
As with blood clearance, the combination of galactosyl- and gluoosyl- or
mannosyl-BSA significantly increase the inhibition of attachment.
Differences in the results of my studies and those of Perry et of.(65) can not
fully be explained by the difference in the type of phagocytic cell used (perito
neal macrophage vs. Kupffer) or the strain of mouse used (BALB/c vs. ICR) or
the different strains of GBS. In my studies, the stringency of my conditions
for detecting inhibition of adherence of GBS to Mo suggests another receptor
or combination of multiple receptors for microorganisms that represents an
efficient and potent defense mechanism for non-opsonin-mediated adher
ence. Possible candidates for these receptors may the macrophage integrins.
The p2 integrins CR3 and LFA-1 have been implicated in the phagocytic
uptake of Staphylococcus epidermidis (96). Preliminary studies in our labora
tory suggest that these leukocyte integrins are also the receptors involved in
attachment of GBS.

CHAPTER 3
CHARACTERIZATION OF THE INTERACTION BETWEEN GROUP B
STREPTOCOCCI AND THIOGLYCOLLATE-EUOTED PERITONEAL
MACROPHAGES

Abstract

Macrophages have been shown by several investigators to recognize and
bind group B streptococci (GBS) in the absence of serum opsonins. The
mechanism for this binding has not been elucidated. I have shown this
mechanism to involve a protein receptor on the macrophage since the
binding of GBS is sensitive to trypsin treatment. Other characteristics of this
binding, such as temperature dependence and a requirement for divalent
cations suggest that the receptor involved is not the lectin-like galactose
receptor. Treatment of the macrophages with 2-deoxy-D-glucose, at concen
trations of 0.5 mM and 50mM, decreased GBS binding by 33% and 90%,
respectively. Two-deoxy-D-glucose has been shown to inhibit Fc and
complement receptor-mediated binding by mouse peritoneal macrophages.
The function of receptors for the third component of complement (C3) to
bind ligand-coated particles may be altered dramatically when macrophages
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attach to surfaces coated with fibronectin (FN) or after macrophages are
exposed to phorbol esters. Here I show that when phorbol dibutyrate (PDB) is
present during the incubation of GBS and macrophages monolayer, binding
doubles. In addition, when macrophages are allowed to attach to an FNcoated surface, in the presence or absence of PDB, binding of GBS also
increases two-fold. Neutrophil elastase has been shownto cleave the C3b
receptor, CR1, but not the C3bi receptor, CR3. When I treated the macrophage
monolayers with neutrophil elastase, the binding of GBS was unchanged.
These results suggest that the binding of GBS by peritoneal macrophages, in
the absence of serum components, may be mediated by CR3.

Introduction

Phagocytic cells in higher animals are capable of discriminating between
foreign material and self components. They are also able to distinguish
between self and alterations to self, as in effete or damaged cellular compo
nents or aberrant self constituents, such as tumor cells (47). The recognition
abilities that underlie this discriminating capacity must have evolved with
the emergence of primitive species. Some form of self recognition mechan
ism is likely to have formed the basis of the abilities of colonial marine
species such as Porifera to exclude unrelated organisms from inclusion in
their colonies (105). In addition the cells lining the cavity of Porifera are
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capable of capturing microorganisms present in the water drawn into the
cavity. Phagocytosis also plays a role in the metamorphosis of insects in
removing dead cells and disintegrated tissue (26). The role of invertebrate
amebocytes in recognizing and engulfing foreign material is likely to be a
development of these earlier, more primitive recognition mechanisms and
begins to involve cooperation with soluble factors present in the hemolymph, acting as opsonins (67).
In vertebrates further specialization has occurred, involving cooperation
between phagocytes and components of the immune system including anti
bodies, complement and lymphoid cells. The more primitive forms of
phagocyte recognition appear, however, to have been retained and the cells
appear to be able to recognize and bind foreign particulate material without
the use of their more recently evolved receptors for the Fc component of the
immunoglobulin molecule or the C3b component of the complement system
(94).
I have observed nonopsonin-mediated binding of group B streptococci
to murine peritoneal macrophages. Attempts to demonstrate adherence of
exposed galactose of the bacterial capsule to the known macrophage mem
brane galactose receptor have been unsuccessful (see Chapter 2). In this study
I have compared characteristics of the adherence of type III GBS to murine
peritoneal macrophages with known characteristics of macrophage bacterial
receptors in an attempt to identify whether a previously characterized mem-
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brane receptor is responsible for this initial recognition.

Material and Methods

Chemicals All chemicals were obtained from Sigma Chemical Co. (St. Louis,
MO) unless otherwise noted.

Bacteria A culture of type m Group B streptococci, designated as strain
COH31, was kindly provided by Dennis Kasper, Channing Laboratory
(Harvard Medical School). This strain was originally isolated from an infant
with meningitis (44). Capsular mutants of GBS type m strain COH31 were
obtained from D. Kasper (Harvard) and are previously described (see Chapter
2). All strains were maintained, and prepared for the assay as previously
described (see Chapter 2).

Macrophages Macrophages were prepared as previously described (see
Chapter 2).

Assay o f GBS adherence Monolayers of macrophages (prepared as previous
ly described in Chapter 2) were layered with 0.2 ml of GBS at densities of
10io/ml and lOVml in DPBS and incubated at 37°C in the CO 2 chamber for 1
h. Bacteria were added and adherence quantified as previously described (see
Chapter 1).
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Treatment o f macrophage monolayers w ith trypsin The procedure for trypsin
treatment of macrophage monolayers was a modification of that devised by
Czop et al. (16). Macrophages were layered with 0.25 ml analytical grade,
bovine pancreatic trypsin (Boehringer Mannheim, Indianapolis, IN) having a
specific activity, determined by the manufacturer, of 40 U /m g lyophilized
material (25°C; benzoyl-L-arginine ethyl ester as substrate). The trypsin was
diluted in RPMI containing an additional 5 mM MgCh, over the range of 4.0
Hg/ml to 4.0 m g/ml, and the treated macrophages were incubated at 37°C for
30 min in the CO2 chamber, and rinsed twice with RPMI. Each monolayer
was then layered with 0.25 ml aprotinin (Trasylol ™, 200 U /m g lyophilizate
trypsin inhibitor units, Boehringer Mannheim) at varying molar concen
trations selected to be the equivalent of the previous trypsin concentration,
incubated for 15 min at 37°C, rinsed four times with RPMI, and overlaid with
wild-type COH31 and the two isogenic strains of GBS for detection of adher
ence. Treatment of macrophage monolayers with aprotinin alone, at any of
the concentrations tested, followed by washing did not inhibit adherence.

Treatment o f macrophage monolayers w ith neutrophil elastase Lyophilized
human neutrophil elastase (Sigma) with a specific activity of 110 U /m g
protein (determined and defined by the manufacturer as: one unit will release
one nanomole of p-nitrophenol per second from N-t-BOC-L-alanine pnitrophenyl ester at pH 6.5 at 37°C) was dissolved in sterile distilled water at
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1 m g/m l and stored in small aliquots at -70°C. Macrophage monolayers were
treated with 0.25 ml of neutrophil elastase at final concentrations of 30,10 and
3 ng/m l in DPBS for 1 h at 37°C, using a modification of the method of Tosi
et al. (100). The elastase was removed by washing the chambers individually
four times with DPBS followed by the addition of GBS for assay of adherence.
In addition, we examined the effect of elastase treatment on macrophage
monolayers morphologically at 1000 X magnification.

Treatment of macrophage monolayers w ith 2-deoxy-D-glucose I used a
modification of the method of Sung and Silverstein (97) to examine the effect
of 2-deoxy-D-glucose treatment of macrophages on their ability to bind GBS.
Briefly, macrophage monolayers were incubated with 500, 50,5.0 and 0.5 mM
2-deoxy-D-glucose for 2 h at 37°C, followed by the addition of GBS to the
monolayers for 1 h at 37°C, without removal of 2-deoxy-D-glucose, for assay of
adherence. The morphological effect of 2-deoxy-D-glucose on macrophages
without the addition of GBS was examined at 1000 X magnification.

Role o f temperature and divalent cations on the adherence o f GBS to macro
phages Macrophage monolayers were incubated with GBS strain COH31 as
described in the adherence assay at 37°C and at the additional temperatures of
20°C and 4°C to determine the effect of temperature on GBS adherence to Mo.
The effect of 0.5 mM MgCfe and CaCh on this adherence was also tested
using a modification of the method of Wright and Jong (116). Thioglycollate-
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elicited peritoneal exudate cells were washed with Ca2+ and Mg2+- free DPBS,
then incubated for 3 h in the chamber-slide to prepare macrophage mono
layers absent of divalent cations. GBS strain COH31 was added to the macro
phages as described for the adherence assay in DPBS containing both Ca2+ and
Mg2+, DPBS containing either Ca2+ or Mg2+ and DPBS without divalent
cations. Macrophage monolayers were exposed to these same conditions
without GBS to observe morphological changes in macrophage adherence to
the chamber-slide during the incubation period with bacteria.

Treatment o f macrophages w ith phorbol ester and/or ligation o f the macro
phage fibronectin receptor on the adherence o f GBS by macrophage mono
layers Preparations of macrophage monolayers was performed as described
previously using eight-chamber tissue culture slides (Lab-Tek) having a
plastic surface which enhances protein coating. Prior to addition of the
peritoneal exudate cells, the plastic slide surfaces were coated with mouse
serum albumin (1 m g/m l) or fibronectin (FN) from rat plasma (0.1 m g/m l) by
a 60 min incubation at 20°C (115). The surfaces were washed three times with
DPBS, incubated for 3 h at 37°C with the cells (0.25 ml/chamber). Where
indicated phorbol dibutyrate (PDB) at 500 ng/m l was included during the
plating of the cells. GBS strain COH31 was added to the macrophages as
described for the adherence assay in the presence or absence of PDB (500
ng/ml). Macrophage monolayers were exposed to these same sets of condi
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tions without GBS to observe morphological changes in macrophage adher
ence to the chamber-slide.

Results

Trypsin sensitivity o f the macrophage capacity to bind Group B streptococci
The effect of trypsin on the capacity of macrophage monolayers to bind GBS
was studied after treatment of the cells with increasing doses of trypsin.
Macrophage monolayers were treated with 4.0,40,400 and 4000 (ig/m l of
purified trypsin, washed twice with RPMI, incubated with aprotinin at
concentration equimolar to the trypsin to inactivate the enzyme, washed
again, and incubated under the usual conditions with 109 and 108/ml GBS.
The number of microscopic Helds analyzed in order to determine the
percentage of 1000 macrophages binding GBS was the same for the trypsin/
aprotinin-treated and aprotinin-treated (control) monolayers. The binding of
five or more bacteria, which was exhibited by about 55% of the untreated
macrophages, for each isogenic strain (Fig. 1), was relatively little affected by
exposure to 4.0 pg/m l of trypsin. GBS binding fell to less than 40% after
treatment with 40 pg/m l for each strain. Increasing the dose of trypsin
further diminished the capacity of the macrophages to bind bacteria; and at
trypsin concentratons of 4 m g/m l, less than 10% of the macrophages were
able to bind GBS. Binding of GBS, without terminal sialic a d d or without
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Fig. 1. Effect of trypsin treatment of Me on GBS binding. (A) strain COH31,
(B) strain COH31/15, (C) strain COH31/21
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capsule, may be significantly less than the binding of wild-type COH31 by
monolayers treated with 40 iig/m l although there are no apparent differences
when monolayers are treated with higher doses of trypsin.

Effect of neutrophil elastaae on macrophage binding to GBS Macrophage
monolayers were treated with increasing concentrations of neutrophil
elastase over the range of 3.0 to 30 p g/m l and washed exhaustively with
DPBS to remove the enzyme prior to the addition of wild-type COH31 GBS.
Treatment of macrophages at each concentration of elastase had no effect on
the percentage of macrophages binding five or more bacteria, determined by
counting 1000 macrophages, when compared to bacterial binding by untreated
macrophages. The percentage of macrophages binding five or more bacteria
remained about 55%. In addition, there was no morphological change, at
1000 X magnification, of the elastase-treated macrophage monolayers.

Effect o f 2-deoxy-D-glucose treatment o f macrophages on the binding o f GBS
Macrophage monolayers were treated with 2-deoxy-D-glucose over the range
of 0.5 to 500 mM for 2 h prior to the addition of bacteria as well as during the
period of bacterial binding. Fig. 2 shows that approximately 55% of untreated
macrophages bound five or more wild-type COH31 GBS, determined by
counting 1000 macrophages. At the lowest concentration of 2-deoxy-Dglucose, 0.5 mM, there was a decrease in binding to 38% macrophages,
followed by an increasing reduction in binding of GBS by macrophages at the
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MACROPHAGE 2-DEOXY-D-GLUCOSE TREATMENT
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Fig. 2. Effect of pretreatment of Mo with the phagocytosis inhibitor, 2-deoxy-D
glucose, on adherence of GBS to these cells.
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higher concentrations of 2-deoxy-D-glucose. A decrease in binding was
maximal at 50 mM, resulting in less than 10% of the macrophages binding
bacteria.

Temperature and divalent cation dependence o f GBS binding A study of the
effect of temperature on the binding of GBS by macrophage monolayers
revealed dramatic differences in the percentage of macrophages binding five
or more bacteria. As shown in Fig. 3 binding was about 60% at 37°C. Binding
was lowered three-fold to 22% at 20°C and was almost absent (3%) at 4°C.
There is an absolute requirement for either Ca?+ or Mg?+ to support adher
ence of GBS to the macrophage monolayers as shown in Fig. 4. However, the
presence of both cations, at 0.25 mM each, increased the percentage of macro
phages binding bacteria from about 35% for either cation to 60%. This is the
maximum binding I have ever achieved in any of my studies where DPBS
was used during the incubation of GBS with the macrophage monolayers.
DPBS (Sigma Chemical Co,) contains 0.9 mM Ca2+ and 0.5 mM Mg2+

Effect of phorbol ester and!or ligation o f fibronectin receptors on GBS binding
In this study I was investigating the effect of phorbol dibutyrate (PDB) on the
ability of macrophages to bind GBS. In addition, I studied the effect of ligation
of the macrophage fibronectin receptor, by itself or in combination with the
presence of phorbol ester, on the binding of bacteria. Figure 5 depicts the
effects of phorbol ester and ligation of the fibronectin receptor on the
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Fig. 3. Effect of temperature on the binding of GBS to murine peritoneal Mo
(N = 8)
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Fig. 5. Effect of phorbol ester and ligation of fibronectin receptor on binding of
GBS to murine peritoneal Me. (See following page.)
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Fig. 5. Effect of phorbol ester and ligation of firbonectin receptor on binding of
GBS to murine peritoneal Me. (A) binding to uncoated surface, (B)
binding to albumin-coated surface, (C) binding to fibronectin-coated
surface. KEY: none - no phorbol ester present; P only = phorbol ester
present only during the plating of Me; unbound ester removed prior to
addition of bacteria; P & B = phorbol ester present during both plating
of Me and incubation of Me with bacteria; B only - phorbol ester
present only during incubation of bacteria with Me
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percentage of macrophages binding five or more bacteria. When
macrophages were allowed to adhere to an uncoated or albumin-coated
surface, percent binding was similiar, about 55%. However, when PDB was
present during the incubation of macrophages and bacteria with an uncoated
or albumin-coated surface, the percentage binding almost doubled (94%).
When PDB was present only during the plating of macrophages to the
uncoated or albumin-coated surface of the slide and then washed away when
non-adherent peritoneal exudate cells were removed, the percentage binding
was lower (70%) than when PDB was present with bacteria, although this
percentage binding was still higher than w ith no PDB treatment. When
macrophages were plated on fibronectin-coated surface, with no PDB
treatm ent, percentage binding as determined by the visual assay was
maximal, 96%. The presence of PDB during plating only, during plating and
binding or during binding only had no effect on the percentage macrophage
binding GBS on a fibronectin coated surface. Thus both exposure to PDB
during incubation of bacteria with Mo and ligation of the fibronectin receptor
lead to an increase in bacterial binding to the Mo. If PDB is present during the
plating of macrophages and then washed away, the effect of increased binding
diminishes.
Morphological changes were observed for those macrophages plated on a
fibronectin coated surface as compared with those attached to the albumincoated or uncoated surfaces. The cells appeared to be covering a greater
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surface area per cell and to be more stellate in shape. The cytoplasm to
nucleus ratio was increased, so that attached or internalized bacteria were
much more visible.

Discussion

A num ber of studies have been described in this paper on the effect of
various enzymes, chemical treatm ents and tem perature on the binding of
GBS to monolayers of murine peritoneal macrophages in the absence of
serum. The purpose of these experiments was to elucidate a mechanism of
non-opsonin-mediated recognition of bacteria by phagocytic cells in order to
have a better understanding of our innate host defenses. Innate immunity is
particularly im portant for individuals in which the immune system may not
be operating optimally, for example in geriatric individuals, infants, indivi
duals w ith a compromised lymphocyte immunity, and for certain sites in the
body such as the lungs in which low serum opsonin concentrations may not
be sufficient to effectively opsonize many bacterial species (28). Previous
studies in our laboratory have demonstrated that this binding is not mediated
by the interaction between galactose exposed on GBS and the galactose recep
tor on the macrophage (see Chapter 2).
The trypsin sensitivity of the macrophage mechanism involved in the
recognition of GBS is compatible with the function of a membrane protein.
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This recognition mechanism appears to be distinct from known macrophage
receptors such as the Fc receptor and the C3b receptor, CR1, whose activities
are resistant to trypsin digestion (36). In addition, in Fig. 1 1 observed that the
presence of capsule or exposure of terminal galctose on the GBS had no effect
on macrophage binding. Working on the assumption that bacterial binding
was mediated by a Me membrane protein, I attem pted to identify this receptor
by comparing parameters of this binding with those of known macrophage
receptors.
Neutrophil elastase has been implicated as a factor that im pairs local host
defenses in chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Tosi et al. (100) showed that this enzyme cleaves CR1 from neutrophils
(PMN) in the lungs of infected patients. The C3bi receptor on these cells, CR3,
is resistant to elastase. My studies with treatm ent of macrophage monolayers
by increasing concentrations of elastase demonstrated no reduction in the
binding of GBS at levels as high as 30 pg/m l. CR1 is sensitive to elastase at
10 ng/m l (100). Neutrophil elastase has been shown to cleave other phago
cytic receptors including the Fc receptor (99).
Two-deoxy-D-glucose has been shown to inhibit Fc and CR3-mediated
phagocytosis of mouse peritoneal macrophages but not mannose receptormediated phagocytosis (97). Phagocytosis does not require protein synthesis
and protein glycosylation, processes interrupted by accumulation of metabo
lites of 2-deoxy-D-glucose in the cell. The mechanism of 2-deoxy-D-glucose
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inhibition of phagocytosis is distinct and may involve a complex series of
events resulting from a depolarized macrophage, a lowered cellular energy
reserve, and may also involve the imbalance in the intracellular pool of ions
critical for phagocytosis (97). Of interest is the finding that despite the large
area of plasma membrane internalized by the macrophage during phago
cytosis, concomitant protein synthesis is not required. Part of this may be due
to the ability of macrophages to recycle their membrane proteins (54). There
are also large numbers of membrane vesicles in the macrophage to replenish
the internalized membrane (87).
The method used in this study for visual quantitation of GBS recognition
by macrophage monolayers cannot differentiate between attached and inter
nalized bacteria. Numbers of internalized bacteria are therefore included in
the data as bound bacteria. Since binding is allowed to occur at 37°C and the
macrophages are viable, macrophages with phagocytosed bacteria probably
contribute to the number of cells scored as positive for binding five or more
bacteria. Therefore, the property of dose-dependent inhibition of binding of
GBS observed in our studies for 2-deoxy-D-glucose may involve CIO, which
has been implicated in the direct binding of other pathogens (115).
The characteristics of tem perature and divalent cations on the binding of
GBS to macrophage monolayers were studied. Binding required either Ca*+
or M g2+ and increased by 50% if both cations were present. This was not the
result of a higher total concentration of ions; the total concentration of cation
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present either individually or jointly was 0.5 mM. Binding was also tempera
ture dependent with maximum binding occuring at 37°C. The requirements
for divalent cations and warm tem peratures are unlike those for the binding
of lectin receptor (I. Ofek, personal commun.) and IgG or C3b-coated particles
(116). However, these characteristics closely resemble the requirements for
binding of particles by CR3 (112).
Receptors for the third component of complement (C3) on cultured
human monocytes bind ligand-coated particles but do not initiate phago
cytosis (32). The function of these receptors, however, is altered dramatically
after monocytes attach to surfaces coated with fibronectin or after monocytes
are exposed to phorbol esters. Fn and phorbol esters "activate" C3 receptors
such that they promote vigorous phagocytosis (116). There is no evidence
that Fc or lectin-like receptors are affected by these treatments. In my adher
ence assay, bacteria that have been internalized by phagocytosis probably
contribute to the number of macrophages observed to bind five or more
bacteria, therefore I studied the effect of macrophages treated with phorbol
esters or plated on a fibronectin-coated surface on the binding of GBS.
In sum m ary I have shown that ligation of FN receptors causes enhanced
"binding" of GBS to macrophages. The effect of ligated FN receptors on the
increase numbers of GBS associated with the macrophages can be mimicked
by PDB. The effect of PDB on increased binding of GBS by macrophages was
shown to be reversible when the phorbol ester was removed. PDB was used

f
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in these studies instead of the more hydrophobic phorbol m yristate acetate
(PMA) since more than one-half of cell-associated PDB may be released from
the cells upon washing 20°C (29).
This study confirms that a macrophage membrane receptor is involved in
the binding of GBS in vitro. Table 1 summarizes data from my studies and
others in comparing the effects of tem perature, elastase, 2-deoxy-D-glucose,
phorbol ester, ligation of FN receptors and divalent cation requirements with
known macrophage receptors. A comparison of binding characteristics for the
macrophage Fc receptor, galactose-receptor and integrin receptor for C3bi,
suggest a similiarity between CR3 and the receptor for GBS.
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TABLE 1
PROPERTIES OF KNOWN BACTERIAL RECEPTORS ON M0
Properties

Receptors
GBS*

Integrin

Lectin

Fc

Tem perature dependence

+

+ (116)b - (105)

- (116)

Trypsin sensitivity

+

+ (16)

- (105)

-(16 )

Elastase resistance

+

+ (100)

?

-(9 9)

Ca2+ and Mg2+ requirement

-

- (116)

+(105)

+ (116)

Ca2+ or Mg2+ requirement

+

+ (116)

-(105)

- (116)

2-deoxy-D-glucose inhibition

+

+ (97)

-(9 7 )

+ (97)

FN-substrate enhancem ent

+

+ (114)

- (114)

- (114)

Phorbol ester enhancement

+

+(114)

- (114)

- (114)

a data from this study
b results compiled from references dted

CHAPTER 4

ROLE OF fc INTEGRINS AND LIPOTEICHOIC ACID IN THE ADHERENCE
OF GROUP B STREPTOCOCCI TO MURINE PERITONEAL MACROPHAGES

Abstract

The type EH group B streptococcus (GBS), an extracellular pathogen, is
recognized by murine peritoneal macrophages (Mo) in the absence of serum
components such as complement or antibody. To understand this non
opsonin m ediated adherence of GBS, I have investigated the role of die Me 02
family of integrin receptors, CR3, LFA-1 and pl50,95, and the bacteriumbound ligand, lipoteichoic add, in the mechanism of adherence. Two mono
clonal antibodies that bind to either subunit of murine CR3, M l/70 and
M18/2, inhibited adherence of GBS to Me; attachment was inhibited by 31
and 66% by M l/70 and M18/2, respectively. The interaction between GBS and
CR3 probably does not involve the C3bi-binding site on CR3, however,
because a monoclonal antibody which exhibits spedfidty for this site, M l/70,
inhibited GBS attachment by only 31%. In contrast, M 18/2, which reacts with
the 0 subunit common to all members of this integrin family, inhibited
ingestion by 66%. The effect of using both monoclonal antibodies was not
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additive. Downmodulation studies using the same antibodies, separately and
in combination, to deplete the receptors from the apical surface of adherent
Me were performed to examine their effect on GBS adherence. Similiar
results were obtained. Results from flow cytometry studies using these same
antibodies in solution with a mixture of suspended bacteria and Mo also
showed sim iliar inhibition profiles. One monoclonal antibody, 5C6, that
ligates a different epitope on the a-subunit of CR3 from M l/70, did not
produce an inhibitory effect on the adherence of GBS to Me by flow cyto
metry. I was unable to use this antibody in downmodulation studies or
inhibition studies requiring a Me monolayer because this antibody recog
nizes a M g2+ -dependent anchorage site on the Me.
A dose-dependent effect of LTA to inhibit the binding of GBS to Me was
observed in all studies using LTA; downmodulation of Me receptors by LTA,
LTA in solution with Me monolayers or in flow cytometry studies with
suspended cells. Inhibition of GBS adherence to Me was maximal (70%) at a
concentration of 30 tig/m l.
My studies suggest the role of LTA and the fe integrins in the binding of
GBS by m urine peritoneal Me. Recognition of phosphosugar surface struc
tures on the extracellular pathogen, GBS, is consistent with other studies
suggesting that a similar surface struture on both intracellular and extracel
lular bacteria is recognized by the CR3, LFA-1 and pl50,95 family of leukocyte
integrins.
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Introduction

Adhesion between phagocytes and other cells, particles, or the extracellular
matrix is crucial for a variety of functions such as phagocytosis, diapedesis,
and positioning of phagocytes in the liver, lungs, and other tissues (103).
Phagocytosis represents an im portant effector mechanism for the eradication
of infectious agents. It is performed primarily by specialized cells of two
different lineages, namely polymorphonuclear neutrophilic granulocytes
(PMN) and mononuclear phagocytes (Me). Because of their major function,
these cells are often referred to as 'professional phagocytes' to distinguish
them from m ost other host cells which are called 'non-professional phago
cytes'. To fulfill these functions, PMN and Me m ust respond to specific
signals that indicate the presence of infectious agents and also collaborate
with the elements of specific immunity. Phagocytosis alone cannot eradicate
invading microbes, it m ust be followed by intracellular killing mechanisms
using specialized organelles and molecules. It has long been assumed that
PMN and Mo have specific receptors for binding microorganisms directly
and specific receptors that mediate cellular adhesions, but only recently have
such receptors been isolated and characterized.
The idea that a few receptors could be responsible for a wide range of
adhesion events first arose with the discovery of a class of patients that exhibit
recurrent life-threatening infections w ith gram-positive, gram-negative and
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fungal pathogens (5). These patients exhibit extreme leucocytosis but fail to
form pus at sites of infection. In vitro experiments showed that PMN from
these patients are defective in their ability to adhere to C3bi-coated erythro
cytes, to protein-coated glass or plastic surfaces (3), and to endothelial cells
(34), and that failure to adhere results in the inability to display chemotactic
responses. Thus, susceptibility to infection probably results both from an
inability to bind and ingest opsonized pathogens and a failure to recruit cells
to sites of infection. Additionally, these observations suggest that the leuco
cytes of patients fail to extravasate and are retained in the vasculature by a
failure to adhere to endothelial cells, giving the name of leucocyte adhesion
deficiency (LAD) to this condition. Characterization of the proteins missing
from the patients' leucocytes have confirmed their role in adhesion to endo
thelium and in several other adhesion events.
LAD is caused by a failure of leucocytes to express three related proteins,
LFA-1, CR3 and p i50,95, of the integrin family of cell-cell and cell-matrix
proteins (90). Each of these cell-surface glycoproteins consists of an a i Pi
dimer composed of a 150,-190,000 Mr a chain and a 95,000 Mr f) chain,
schematically depicted in Fig. 1. The f) chain is identical in each of these three
proteins (77) and has been given the designation CD18 by the International
Workshop on Leucocyte Antigen Differentiation. The a chains are struc
turally and antigenically distinct (113). The a chains of LFA-1, CR3 and
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Fig. 1. Schematic structure of an integrin. Taken from Steven M. Albelda
and Clayton A. Buck. 1990. Integrins and other cell adhesion molecules.
FASEB J. 4:2868-2880.
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pl50,95, are termed C D lla, C D llb and C D llc, respectively, and CR3 is referred
to as CDllb/CD18.
LAD patients are deficient in all three of these proteins because of an
inherited defect in the p chain (90). Cells from LAD patients do synthesize
normal precursors of the a chains, but these precursors are very rapidly
degraded and do not appear on the cell surface. Patients have recurring
infections, often fatal in childhood unless they are corrected by bone marrow
transplantation. In a study by Ross et al. (73), children with LAD had
recurrent skin infections w ith Staphylococcus epidermidis but not yeast
suggesting the role of CR3 and LFA-1 in the phagocytosis of unopsonized
bacteria.
Lymphocytes express abundant LFA-1, but neither CR3 or pl50,95. PMN
express abundant CR3, whereas LFA-1 and pl50,95 are minor but easily
detectable components. Macrophages express large amounts of all three of
these proteins. Expression of these proteins appears to be restricted to
leucocytes; they have not been found on other mammalian cell types.
The first molecule shown to be deficient from LAD patients (5) had been
previously identified as a receptor for a cell-bound fragm ent of complement
(114) and was named CR3 (complement receptor type three). CR3 has also
been referred to as Mac-1 and Mol because it was the first phagocyte-specific
antigen identified by monoclonal antibodies in mouse and man, respectively.
CR3 functions as an opsonic receptor, and promotes the binding of C3bi
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coated cells and particles by monocytes, macrophages and PMN (112,117). In
appropriately stimulated cells, binding is followed by phagocytosis of the
particle but does not induce reactive oxygen metabolites (21). Therefore, CR3
provides a safe way for entry into professional phagocytes, compared to inter
nalization via the Fc receptor. Most intracellular pathogens except viruses,
have been shown to use CR3 for entry into mononuclear phagocytes. Exam
ples are Legionella pneumophila, (63) Mycobacterium tuberculosis, (64),
Leishmania sp. (98), and Histoplasma capsulatum

(12).

CR3 requires relatively high concentrations of divalent cations (about 0.5
mM Ca?+ and Mg?+) in order to interact effectively with ligand (112). Integrin
a-subunits have three or four tandem repeats of a putative divalent cationbinding motif, and have been shown to require

Ca2+

or Mg2+ for function (91).

This behavior contrasts with that of other opsonic receptors (CR1 and FcR)
which do not require divalent cations for binding activity. In addition, the
binding capacity of CR3 is tem perature dependent, and is absent in cells held
at 0°C (117), again distinguishing CR3 from other opsonic receptors (CR1 and
FcR) which bind well at 0°C.
In the presence of serum, most pathogens are taken up via C3bi deposi
tion on their surface. CR3 does not recognize either the precursor C3b, or the
product of further cleavage C3dg (14, 72,112). Binding of monomeric or
dimeric C3bi to CR3 has not been reported, presumably because of low bind
ing affinity. Studies using sheep erythrocytes coated with 104 to 105 C3bi per
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cell dem onstrate avid binding to CR3-bearing cells presumably because of
m ultivalent interaction with the phagocytes. By analogy, it is likely that LFA1 and p i50,95 also bind their targets w ith low affinity and that adhesion
events m ediated by these receptors are driven by m ultivalent interactions. A
functional consequence of low affinity binding is the potential to reverse
adhesion and prom ote detachment.
CR3 has two distinct binding sites. One is located on the a chain and binds
ligands such as C3bi, containing the Arg-Gly-Asp (RGD) sequence. In the
absence of C3bi, microorganisms expressing a surface protein containing the
RGD sequence could bind to CR3. For example, Bordetella pertussis, a gramnegative coccobacillus and the causative agent of whooping cough, has been
shown to adhere to human macrophages, in vitro. The interaction between
macrophage CR3 and B. pertussis filamentous hem agglutinin (FHA)
involves recognition of the RGD sequence at positions 1097-1099 in FHA (68).
The other binding site on the a chain of CR3 has a lectin-like character
and, for example, recognizes lipopolysaccharide (LPS) located on the outer
leaflet of the outer membrane of Escherichia coli (116). Histoplasma
capsulatum binds directly to CR3 via the lectin-like binding site (12). In
addition, an abundant surface glycolipid, promastigote lipophosphoglycan
(LPG), from Leishmania has been shown to bind to the lectin-like-LPS'
binding site on the a chain of QR3 (76,98). It is possible that LPS, LPG and H.
capsulatum display a common structure, such as a sugar phosphate, that can
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be recognized by CR3 (116).
Characterization of the non-opsonic binding param eters of Group B
streptococci (GBS) and m urine peritoneal macrophages in our laboratory (see
Chapter 3) has suggested a similiar binding profile for the 'GBS-receptor' and
CR3, based on divalent cation and tem perature dependence, trypsin sensiti
vity, elastase resistance and 2-deoxy-D-glucose inhibition. Group B strepto
cocci contain membrane teichoic acid, lipoteichoic ad d (LTA) which is known
to mediate the adherence of GBS to human embryonic, fetal and adult epithe
lial cells (55). Hydrophobic interactions due to the lipid fatty add portion of
the polymer and possibly other cell surface components within the plasma
membrane of embryonic and fetal cells has been suggested as a mechanism
for adherence. Interaction of the glycerol phosphate backbone with specific
receptor sites on the cell may follow or occur independently for the attach
ment of GBS to adult cells (55). The teichoic add moiety of GBS LTA (55) and
Group A streptococd LTA (58) has been implicated in the ability of these
microorganisms to adhere to neonatal tissue. Competition binding experi
ments using soluble LTA may help to confirm if a structure such as a sugar
phosphate, common to LTA, LPS, and LPG in involved in the binding of GBS
to m urine peritoneal macrophages. Positive evidence w ould support the
theory that the GBS receptor is CR3.
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M aterials and M ethods

Chemicals All chemicals were obtained from Sigma Chemical Co, (St. Louis,
MO) unless otherwise noted.

Bacteria Type m Group B streptococci, designated as strain COH31, was kindly
provided by Dennis Kasper, Channing Laboratory for Infectious Disease
(Harvard Medical School). This strain was originally isolated from infants
with meningitis (44). It was grown and maintained in our laboratory as
previously described (see Chapter 2).

Assay o f GBS adherence Monolayers of macrophages (prepared as previous
ly described in Chapter 2) were layered with 0.2 ml of GBS at densities of
10io/ml and 10* /m l in DPBS and incubated at 37°C in the CO2 chamber for 1
h as previously described (see Chapter 1).

Hybridoma lines and MAh The characteristics of the antibodies used in this
study are summarized in Table 1. The derivation of rat anti-mouse subdoned
lines of Ml/70.15.11.5 (89), M 18/2a.l2 (78) and 5C6 (71) has been previously
described. The sub-clones Ml/70.15.11.5 (ATCC TIB 128) and M 18/2a.l2.7
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TABLE 1
RAT ANTI-MOUSE MAb TO 02 INTEGRINS

MAb

Origin

Epitope

Isotype

Ml/70.15.11.5a

T. A. Springer

a subunit of CR3,

IgG2b

(89)

inhibits C3bi binding

S. Gordon (71)

a subunit of CR3, inhibits

5C6

lgG2b

Mg2if -dependent binding

M18/2a.l2.7a

T. A. Springer

02 subunit of CR3, LFA-1,

(78)

and pl50,95

a purified from hybridoma supernatants by protein G affinity
chromatography.

IgG2a
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(ATCC TIB 218) were obtained as frozen suspensions (American Type Culture
Collection, Rockville MD). For brevity, these subdones will be designated as
M l /70 and M18/2. The 5C6 antibody was purchased as purified IgG from
Serotec (Kidlington, Oxford, designated as MCA 711).
To obtain large quantities of purified MAb, the hybridoma line of M l/70
was grown in Dulbecco's modified Eagle's medium (D-MEM) with 4.5 g /L
glucose and the M18/2 line was grown in RPM I1640, w ith 5 x 10*5 M 2-mercaptoethanol. Both media were supplemented with 10% low IgG fetal bovine
serum (Hyclone Laboratories, Logan, Utah), 2mM L-glutamine and penicillinstrep tomyrin. The cell lines were grown in 75 cm2 flasks, at 37°C in a humidi
fied atmosphere of 5% CO2 and 95% air, to densities exceeding lOVml to
exhaust the media. The supernatant, containing secreted antibody, was
removed from the cells by centrifugation (100 xg). MAb were purified by 50%
saturated (N H ^SC ^ precipitation and affinity chromatography on Protein G
Superose® 4 Fast Flow (Pharmacia LKB Biotechnology, Piscataway, NJ)
equilibrated with 20mM phosphate-buffered saline, pH 7.0 (PBS), containing
0.1% thimerosal. The IgG was eluted with 0.1 M glycine, pH 2.7, and collected
as 1.5 ml fractions in tubes containing 45pl 1.0M Tris-HCl, pH 9.0 to preserve
the activity of the ad d labile IgG. Column size and flow rates were deter
mined by the rat IgG2a and IgG 2b binding properties quoted in the data sheet
accompanying the affinity chromatography product.
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Lipoteichoic acids Purified and lyophilized lipoteichoic ad d from Strepto
coccus pyogenes (group A streptococci) prepared in the laboratory of the late
Edwin H. Beachey, University of Tennessee (Memphis, TN) was kindly pro
vided by Itzak Ofek, Tel Aviv University (Tel Aviv, Israel). Purified LTA
from Streptococcus agalatiae GBS was kindly provided by Stephen J.
Mattingly, University of Texas, (San Antonio, TX). Solutions of each type of
LTA at 10 m g/m l were prepared in sterile water to prevent deacylation. The
LTA was diluted into DPBS, pH 7.2, immediately before use to the concen
trations desired for the inhibition assays.

Inhibition studies using MAbs or LTA Macrophage monolayers were
preincubated for 30 min at 37°C with soluble MAbs or LTA in DPBS before
the addition of bacteria to study their effect on GBS adherence to peritoneal
macrophages. Solutions containing various MAbs, alone or in combination,
each at a final concentration of 10 and 50 jig/m l, or LTA at 75,150,300 pg/m l
were added to the monolayers. Normal rat IgG and FBS were used as nega
tive controls for the antibody studies. The effect of group A streptococcal LTA
on binding was also studied by co-incubation of the monolayers with bacteria
and the LTA, without the h ead start'.

Downmodulation Studies The ability of solid phase MAb to down-modulate
macrophage CR3 and inhibit GBS binding was examined by coating 8chamber glass slides (Lab-Tek) with the MAbs, alone or in combination, at
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concentrations of 10 and 50 |i.g/m l in 0.1 M carbonate-bicarbonate, pH 9.6
overnight at 4°C. The effect of macrophages adhering to a surface coated with
group B streptococcal LTA on bacterial binding was also studied. Since LTA
contains both hydrophobic and hydrophilic regions, I allowed LTA to adhere
to both plastic and glass slides for my studies of inhibition of adherence. It
was possible that one of these surfaces would provide a better substrate for
LTA, based on its different regions. The slides were coated overnight at 4°C
with DPBS containing LTA at 30,300 and 3000 ng/m l. After removing
unbound MAbs or LTA with DPBS, peritoneal exudate cells were added to
these slides as described above to prepare macrophage monolayers. Bacteria
were added to these slide for the binding assay. Rat IgG and FBS were used to
coat slides as negative controls for inhibition.

Flow cytometry To examine the adherence of GBS by macrophages in suspen
sion, flow cytometric analysis of fluorescent GBS bound to macrophages was
performed by the use of a FACStarPLUS (Becton Dickinson, FACS Systems,
Sunnyvale, CA) with computer-assisted evaluation of data (FACStarn-us
Lysys II software). To label the bacteria w ith a fluorochrome, I chose Lucifer
Yellow VS. Lucifer Yellow (LY) (95) is the vinyl sulfone derivative of a
sulfonated 4-amino napthalim ide molecule with spectral properties similiar
to the more commonly used fluorescein isothiocyanate.

Unlike the fluore

scein, however, the fluorescence intensity of LY is stable from pH 2 to pH 10.
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Thus, LY fluorescence is unaffected by pH changes achievable in endocytic
vesicles or lysosomes (48). When LY was linked covalently to amino and
sulfhydryl groups on the surface of Streptococcus pneumoniae, Sveum et al.
(95) reported quantitation of macrophage-associated bacteria at all stages of the
adherence and ingestion phases of phagocytosis.
Labelling of bacteria was achieved by incubating 1010 GBS and 1 mg of
Lucifer Yellow VS (LY) in 1.0 ml of 0.1 M NaHCOa, pH 9.5, for 2 h at room
tem perature, then washing the cells five times in DPBS (95). Washed perito
neal exudate cells containing 95% macrophages at 2 x 106/m l and LY-GBS at
10®/m l, in DPBS, were incubated for 1 h at 37°C to allow for binding to occur.
Cells were fixed by addition of an equal volume of 2% formaldehyde and
samples were either examined immediately or stored at 4°C for up to two
weeks before analysis by flow cytometry.
The effect of MAb or GBS-LTA on adherence of GBS was investigated by
preincubating the macrophages for 30 min at 37°C with MAb M l/70, M18/2
or 5C6, at 10 and 100 pg/m l, or LTA at 30 and 300 pg/m l, before the addition of
bacteria. The emission of Lucifer Yellow-labeled GBS attached to macro
phages was recorded at 530 nm after excitation by the argon laser at 488 nm.
Data were acquired by using an instrum ent status w ith a linear data mode for
Forward Scatter (FSC) and Side Scatter (SSC) and a logarithmic data mode for
Filter 1 (Fll) for 530 nm. The FSC threshold was raised to eliminate unbound
bacteria, red blood cells, platelets and and a live gate was set around the macro-
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phages in the control.
The Kolmogorov-Smimov (K/S) Two-Sample Test was used to test for
inhibition of bacterial adherence to macrophages by MAb or LTA. K /S
calculates the probability that two histograms are different by computing the
summation of the curves and finds the greatest difference between the
sum m ation curves.

Results

A macrophage fa integrin mediates adherence o f group B streptococci To
explore the role of the macrophage fc integrins in m ediating adherence of
GBS to peritoneal macrophages, I examined the capacity of MAb directed
against either subunit to inhibit bacterial adherence. The cumulative data
from two experiments, using soluble antibodies and macrophage monolayers,
are shown in Table 2. MAb M18/2, directed against the ^-subunit CD18
common to all three members of the 02 integrins, significantly inhibited GBS
adherence. Monoclonal antibody M l/70, directed against the C3bi binding
site on the a-subunit, C D llb, also inhibited GBS adherence but to a lesser
degree. The mean inhibition for M 18/2 was 66% and mean inhibition for
M l/70 was 31%. When the antibodies were used in combination the mean
inhibition was 70%. When the monoclonal antibody 5C6, with specificity for
the Mg2+ -dependent anchorage site on C D llb, was tested for its effect on
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TABLE 2
INHIBITION OF STREPTOCOCCAL ADHERENCE TO Mo BY
MONOCLONAL ANTIBODIES

Antibodies Used

M l/70

M18/2

Percent
Inhibition*

p Value**

Polyclonal IgG

—

—

—

0

0

—

-

-

+

3

3

—

-

+

-

64

67

0.006

+

-

-

33

28

0.008

+

+

67

72

0.001

* Results of two separate experiments
b Based on analysis of variance, p Values based on comparisons between
effect of each MAb and IgG control. There was no significant difference
between IgG control and control with no antibody added. There was no
significant difference between the effect of M l/70 alone and in combina
tion with M18/2 (p = 0.304).
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inhibition of GBS adherence, the macrophages appeared to become less
adherent and many were removed from the surface of the slide with the
subsequent washings. Therefore, whenever this antibody was included in my
tests I was unable to obtain results for its effect on macrophage binding of
GBS. Control antibody, polyclonal rat IgG, did not significantly inhibit GBS
adherence (mean inhibition, 3%).
Downmodulation studies using antibodies M l/70 and M 18/2 demon
strated a sim ilar inhibition profile. As shown in Table 3 the mean inhibition
of GBS adherence for macrophages attached to a M18/2 -coated surface, from
two experiments, was 59% and the mean inhibition for M l/70 was 28%.
When both antibodies were used, mean inhibition was 62%. Macrophages
attached to the glass slide coated with MAb 5C6 appeared to be very unstable.
The cells were not well attached (i.e., they appeared rounded up) and were
easily removed by washing with DPBS. Therefore this antibody was not used
in the downmodulation studies. When macrophages were allowed to attach
to a polyclonal rat IgG-coated surface there was no significant inhibition of
GBS binding.
When flow cytometry was employed to study the binding of GBS to macro
phages it was possible to quantify bacterial binding without having to wash
away unbound bacteria. Figure 2 compares the fluorescence intensity of
unstained GBS with that of LY-labelled GBS. For this method we kept the
macrophages in suspension by using siliconized microcentrifuge tubes;
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TABLE 3
EFFECT OF DOWN-MODULATION OF INTEGRIN ON STREPTOCOCCAL
BINDING TO M0

A bused

Specificity

Percent

p Valueb

Inhibition*

N one

0

0

3

3

—

IgG

polyclonal

M l/70

CR3 a chain

26

30

0.006

M18/2

fc chain

57

61

0.001

M1/70 + M18/2

a and fe chains

60

64

0.001

* Results of two separate sets of experiments. Positive binding: S 5
bacteria/M 0. 1000 M 0 counted for each entry
b Based on analysis of variance, p Values based on comparisons between
effect of each MAb and IgG control. There was no significant difference
between IgG control and control w ith no antibody added. There was no
significant difference between the effect of M l/70 alone and in combina
tion with M18/2 (p = 0.400).
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UNSTAINED GBS
LUCIFER YELLOW GBS

Fig. 2. Fluorescence histograms of unlabeled and LY-labeled group B
streptococci.
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therefore I was able to test the effect of MAb 5C6 (against the anchoragedependent site) on the binding. Figures 3-5 are overlays of fluorescence
histograms comparing the FSC w ith fluorescence intensity, for unstained GBS
binding to macrophages, w ith maximum fluorescence of LY-labelled GBS
binding to macrophages as well as the effect of MAb M 18/2, M l/70, and 5C6
on the fluorescence intensity of the GBS-bound macrophage.
The K /S statistic, D /s(n), is an index of similarity for two curves. [s(n) =
square root of (ni + n 2)/(n i * n 2>, where ni is the number of events in the
first histogram; n 2 is the number of events in the second histogram] If D /s(n)
= 0, the curves are identical. A value of 5.0 or greater indicates a statistically
significant difference between two curves. Table 4 summarizes the D /s(n)
statistic for each concentration of MAb. Monoclonal antibody M l/70, recog
nizing C D llb ((Xr,-subunit) and M18/2, recognizing CD18 ({)-subunit) each
inhibited the adherence of GBS to macrophages. The monoclonal antibody
5C6, recognizing a different epitope on C D llb was not inhibitory. These data
are consistent w ith downm odulation and soluble inhibition studies using
MAbs, supporting the role of fc integrins in the binding of GBS.

The role o f LTA in the recognition o f GBS by peritoneal macrophages The
effect of soluble LTA from group A and group B streptococci on GBS binding
by macrophage monolayers was studied in two separate experiments. Figure
6 shows the cumulative data from both studies. For my first studies only

100

M W 0

INHIBITION

MACS + UN GBS

\

MACS + GBS

\

V

M l/7 0 100 UG/ML
M l/7 0 10 UG/ML

75*

Fig. 3. Effect of monoclonal antibody M l/70 on adherence of LY-labeled GBS
and Me. Overlay of histograms for controls: Me + unlabeled GBS
dem onstrates inherent fluoresecence of Me; Me + LY-labeled GBS
dem onstrates maximum fluorescence intensity w ithout antibody.
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Ml8 ^ 2 INHIBITION

MACS + UN GBS

M l8 / 2
\ \

Ml 8 / 2

100 UG/'ML
10 UG/'ML

74-

Fig. 4. Effect of monoclonal antibody M 18/2 on adherence of LY-labeled
GBSand Me. Overlay of histograms for controls: Me + unlabeled GBS
dem onstrates inherent fluoresecence of Me; Me + LY-labeled GBS
dem onstrates maximum fluorescence intensity w ithout antibody.
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5C 6 INHIBITION

MACS + UN GBS

\

MACS + GBS
I

\V \

5C6 100 UG^ML
5C6 10 UG/ML

f j

Fig. 5. Effect of monoclonal antibody 5C6 on adherence of LY-labeled GBS and
Me. Overlay of histograms for controls: Me + unlabeled GBS
dem onstrates inherent fluoresecence of Me; Me + LY-labeled GBS
dem onstrates maximum fluorescence intensity w ithout antibody.

103

TABLE 4
KOLMOGOROV-SMIRNOV ANALYSIS OF FLUORESCENCE HISTOGRAMS
ASSESSING THE EFFECT OF MONOCLONAL ANTIBODIES TO
LEUKOCYTE INTEGRINS ON BINDING OF GROUP B STREPTOCOCCI TO
MURINE MACROPHAGES

Concentration

Monoclonal Antibody
M l/70

M18/2

M5C6

10 Mg/ml

11.67*®

3.23

1.75

100ng/m l

10.65*

10.05*

2.68

®Numbers refer to D /s(n) values. See text for details. Values greater than 5.0
are considered statistically significant and are noted by an asterisk.

0

100
200
LTA (jig/ml)

300

GBS LTA: HEAD START
GAS LTA + COH 31
GAS LTA: HEAD START

Fig. 6. Inhibition of bacterial binding to Me by lipoteichoic add
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group A streptococcal (GAS) LTA was tested. GBS binding by macrophage
monolayers pre-exposed to this LTA were compared with monolayers
exposed to LTA only during the incubation with bacteria. When macro
phages are preincubated ('head-start') with GAS-LTA, there was a greater
effect on inhibition of bacterial binding than when macrophages were
exposed to LTA only in the presence of bacteria. A second study showed a
similiar dose-dependent inhibitory effect on the binding of GBS when the
macrophages were pre-exposed to LTA from GBS as well (Fig.6).
To further examine the role of LTA in the binding of GBS, macrophages
were allowed to adhere to glass or plastic surfaces coated w ith LTA from
group B streptococci. By analogy with the downmodulation studies using
monoclonal antibodies to CR3, specific receptors for LTA would be expected to
diffuse to the substrate-attached portion of the macrophage, where they are
trapped by interaction with the surface-bound LTA, leaving the apical surface
of the cells devoid of LTA receptors. As shown in Fig. 7 GBS binding to
macrophages was inhibited to a high degree (>60%) when either glass or
plastic slides were coated with LTA at concentrations of 30 pg/m l or greater,
suggesting the existence of a receptor on the macrophage that recognizes LTA.
When flow cytometry was used to observe the effects of LTA on the ability
of macrophages to bind GBS, I obtained results that were consistent with the
previous downmodulation and inhibition studies. Figure 8 is an overlay of
fluorescence histograms comparing the FSC with fluorescence intensity for

% inhibition

0
■

glass slide
plastic slide

LTA (n g /m l)

Fig. 7. Effect of downmodulation of LTA receptors on bacterial binding
by Mo
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LTA I N H I B I T I O N

MACS + UN GBS

MACS + GBS
LTA 300 UG/ML
1

Y,

LTA 30 UG/ML

Fig. 8. Effect of lipoteichoic add on adherence of LY-labeled GBS and
Me. Overlay of histograms for controls: Me + unlabeled GBS
dem onstrates inherent fluoresecence of Me; M e + LY-labeled GBS
dem onstrates maximum fluorescence intensity w ithout LTA.
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unstained GBS binding to macrophages w ith maximum fluorescence of LYlabelled GBS binding to macrophages as well as the effect of LTA on the
fluorescence intensity of the GBS-bound macrophage. The D /s(n) statistic for
LTA at 30 pg/m l was 1.17, indicating no significant difference from the
untreated system. Significant inhibition of GBS binding to macrophages,
however, was observed for a concentration of LTA at 300 p g /m l (D /s(n) =
10.49). These data are consistent w ith downmodulation and soluble inhibi
tion studies using LTA, supporting the role of LTA in streptococcal recogni
tion by the macrophage.

Discussion

Macrophages can recognize group B streptococci in the absence of IgG and
complement proteins. I show here that a family of three structurally related
receptors on macrophages, CR3, LFA-1 and pl50,95, are involved in recogni
zing group B streptococci. When a monoclonal antibody, M l/70, that recog
nizes the a-subunit of CR3 was added to macrophages or used to downmodulate or ligate CR3 on macrophages, the binding of GBS was reduced (Table 3).
The binding of GBS may be reduced to a greater degree when a monoclonal
antibody, M 18/2 that recognizes the ^-subunit, common to all members of
the family, is used in these same studies. The monoclonal antibody 5C6, that
recognizes a different epitope from M l/70 was not inhibitory. These results
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suggest two possibilities for the GBS receptor on macrophages. Either the
receptor is CR3 and the binding site is located near the epitope recognized by
M 18/2 on the ^-subunit or all three members of the

family of integrins,

CR3, LFA-1 and pl50,95, are involved. This mechanism of recognition may
thus serve in the initial response of cells to bacteria, before the generation of
specific immunity. Consistent w ith this view are the observations on several
patients whose cells lack the common (1-chain of CR3, LFA-1 and p i50,95 and
thus express none of the m ature

dimers on their cell surface (26). These

patients suffer recurrent infections (73).
W right and Jong (116) have shown that each of the three structurally
related receptors on macrophages, CR3, LFA-1 and pl50,95, is capable of recog
nizing E. coli. Their observations suggest that the receptors m ust bind the
hydrophilic portion of lipopolysaccharide that extends from the E. coli
membrane. Since the hydrophilic protion of lipid IVa is composed of
diglucosamine bisphosphate, the authors suspect that a disaccharide or sugar
phosphate provides the structure that is recognized. It is possible that the
three proteins, CR3, LFA-1, and pl50,95, each recognize subtly different
residues in order to provide a greater spectrum of target molecules. Talam&sRohana et al. (98) have shown that the abundant surface glycolipid, lipophosphoglycan (LPG) from Leishmania mexicana prom astigotes directly binds to
members of the CR3, LFA-1, and pl50.95 family of leukocyte integrins by the
'TPS" binding site. Bullock and W right (12) have shown that all three
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member of the CR3, LFA-1 and pl50,95 family share the ability to recognize
Histoplasma capsulatum. Five novel phosphoinositol-sphingolipids have
been purified from the yeast phase of H. capsulatum (8,9). The sphingolipids
possess an identical inositol phosphoceramide core. Thus the ligand on H.
capsulatum, the phosphosugar of its sphingolipids, may also be recognized by
the 'TPS" binding site of the leukocyte integrins.
Experiments by Rosset al. (74) suggest that CR3 expresses a lectin-like bind
ing site that is distinct from the C3bi-binding site on the a-subunit. This
lectin-like binding site may be located on the shared {J-subunit, since all three
member of this integrin family bind to H. capsulatum.

Monosaccharides, (J-

glucan and yeast mannan failed to block the binding of H. capsulatum to
macrophages (12). In my own previous studies (see Chapter 2) using monosac
charides and neoglycoconjugates of bovine serum albumin I was unable to
block the binding of GBS by mouse peritoneal macrophages. These studies
suggest the role of phosphosugars as candidates for the lectin-like recognition
site.
Membrane teichoic ad d from group B streptococd, lipoteichoic ad d (LTA)
binds to a trypsin-sensitive glycoprotein receptor on human adult buccal epi
thelial cells due to specific interactions with its glycerolphosphate backbone
(56). My studies on the binding of GBS by macrophages strongly suggest that
the ligand on GBS that is recognized by the macrophage receptor is lipotei
choic add. When macrophages are exposed to soluble LTA prior to GBS, the
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binding of bacteria is reduced. Further, LTA-coated surfaces downmodulate
the capacity of macrophages to bind GBS.
The site on LTA that is recognized by the macrophage receptor has not
been determined. I might presume that because the receptors bind to LTA
that is inserted into GBS membranes, the receptors m ust bind to the hydro
philic portion of the molecule that is composed of sugar phosphates. This
would be consistent with the binding of other bacterial phosphosugar surface
structures by the leukocyte integrins (12,77,98,116). My studies suggesting
the role of LTA and the fc integrins in the binding of GBS by m urine perito
neal macrophages offer additional support for the role of this family of recep
tors in the recognition of extracellular pathogens.

OVERALL DISCUSSION

The receptors and ligands involved in mediating non-opsonic adher
ence of group B stretococci by m urine peritoneal macrophages have been
explored previously, but not identified. The overall goal of this study was to
identify and characterize the receptor on the macrophage responsible for
recognition of the bacteria. My premise is that macrophages are at times
responsible for cellular defenses in the absence of serum factors such as
complement components, and before the induction of specific recognition
molecules, antibodies. Macrophages therefore, m ust have the ability to distin
guish self from non-self, independent of soluble molecules. For these studies
it was necessary to develop adherence assays that could quantify adherence of
GBS to m urine macrophages in order to test various substances for their role
as inhibitors of binding. I developed two adherence assays, one visual and
the other an enzyme-linked immunosorbent assay. Adherence results from
these two assays correlate well. These adherence assays as well as those of
others show that bacteria do indeed adhere to macrophages under a variety of
in vitro conditions, suggesting the presence of membrane structures on these
cells with the ability to recognize complementary structures on the bacterial
surface.

Two groups of macrophage membrane receptors have been impli

cated in microbial recognition, cell-associated lectins, such as the galactose
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receptor, and the integrins. The strategy of this study was to determine if
either or both of these molecules was involved in bacterial recognition.
Using the adherence assays developed in Chapter 1 ,1 investigated the
role of the galactose receptor lectin on the macrophages for binding GBS.
Methods comparing isogenic strains of GBS with exposed galactose, neura
m inidase-treated bacteria which exposed capsular galactose, and inhibition
studies using soluble galactose, BSA-glycoconjugates of galactose as well as
other monosaccharides failed to prove the involvement of the macrophage
galactose lectin. The stringency of my assay methods and the exhaustive
testing using different forms of GBS encourages my findings to dispute other
investigators who have shown the attachm ent of GBS via the lectin receptor
for galactose on the macrophage surface.
I then showed that the mechanism for binding of GBS by macro
phages, such as temperature (118) and divalent cation dependence (91),
protease sensitivity (100), fibronectin and phorbol ester enhancement (115)
and 2-deoxy-D-glucose inhibiton (97) were similiar to those of integrin mole
cules, especially CR3. The presence of monoclonal antibodies to CR3, in
downmodulation studies, or as soluble competitors for GBS and macrophage
monolayers, using the visual assay, or in macrophage suspensions detected by
flow cytometry yielded similiar degrees of inhibition which would suggest the
involvement of the receptor for complement component C3bi in the recogni113

tion of GBS.
Talamas-Rohana^f al. (98) have described two classes of ligands for
CR3. C3bi and fibrinogen possess the peptide RGD (Arg-Gly-Asp) recognized
by the a-subunit. The Leishmania lipophosphoglycan and E. coli lipopolysaccharide are recognized by a separate site on CR3 (116). The inability of MAb
M l/70, which recognizes the C3bi binding site, to block adherence as effective
ly as MAb M18/2, which recognizes the P-subunit (CD18) common to all
members of the leucocyte integrin family of receptors, indicates that attach
ment of GBS may involve a bacterial ligand similiar to the phosphosugars of
Leishmania and E. coli. My studies using purified membrane teichoic ad d
from GBS, lipoteichoic add, as an effective inhibitor of macrophage adher
ence suggest its role in the adherence of GBS via a site on CD18.
Macrophages recognize GBS in the absence of IgG, complement pro
teins, or bacterial proteins. This novel mechanism of recognition of a grampositive, extracellular pathogen may thus serve as an initial response of cells
to baderia, before the generation of specific immunity. Consistent with this
view are the observations on several LAD patients whose cells lack the
common P-subunit of CR3, LFA-1 and pl50, 95 and express none of the
mature

on their cells surface (91). These patients suffer from recurrent

bacterial infections. The basis for the susceptibility of neonates as compared
with adults to GBS infection still remains an area for speculation. The
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predom inant hypothesis for this observation is based on evidence of
decreased complement levels and function in neonates vs. adults (23).
Reduced levels or function of CR3 in neonatal vs. adult macrophages might
explain the differential susceptibility of neonates to bacteria whose uptake is
CR3 dependent.

Note in added proof.
In a recent study by Antal et al. (2), the authors report the role of CR3 in
the opsonin-independent phagocytosis of heat-killed group B streptococci by
the mouse macrophage-like cell line, PU5-1.8 (monocytic tum or, BALB/c) and
resident peritoneal macrophages from BALB/c mice. Downmodulation of
surface Mac-1 (CR3) on macrophages following adherence to anti-Mac-1(M l/70) or anti-CD18- (M18/2) coated surfaces inhibited uptake of GBS, scored
by microscopic examination. Soluble anti-Mac-1 inhibited phagocytosis of
GBS by as much as 50% for both mouse peritoneal macrophages and the
macrophage cell line, whereas soluble anti-CD18 had no effect.
These data support our own studies w ith one exception. We report
that soluble M l 8 /2 (anti-CD18) inhibits the binding of GBS to murine
peritoneal macrophages almost twice as effectively as soluble M l/70 (anti-MacD/ suggesting that binding site might be on the p-subunit and GBS adherence
may be relevant for all members of the leukocyte family of integrins. This
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result may be explained by differences in the cell surface of resident vs.
thioglycollate-elidted peritoneal macrophages and between heat-killed and
live bacteria.
Our studies using LTA to inhibit adherence of GBS to macrophages
suggests a major role for the lectin site on the p-subunit leukocyte integrins
for the binding of GBS consistent with other studies dem onstrating adherence
of £. coli (116) and Leishmania (98), through their phosphosugars, LPS and
LPG, respectively. Antal et al. indicate (no data shown) that soluble anti-CD18
inhibits GBS uptake by human cells but not mouse cells, supporting the role
of the p-subunit in bacterial adherence. In this recent study, using mouse
macrophages, the authors postulate that inhibited phagocytosis of GBS may
involve blocking of a recognition site on CR3 by anti-Mac-1 or may involve
some antibody-induced inhibition of a general signalling functon of CR3 in
phagocytosis. Their study does not clearly differentiate these possibilities.
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